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 Thesis Aims 
This thesis brings together a series of experiments to examine the aetiology of acid-
induced distal oesophageal squamous mucosal damage in humans. Firstly, a review 
of the literature on gastro-oesophageal reflux disease, nitrite chemistry, the histology 
of  the  gastro-oesophageal  junction  and  the  role  of  obesity  in  reflux  disease  is 
undertaken.  Subsequent  chapters  report  studies  of  healthy  adult  volunteers 
investigating the effect salivary nitrite has on gastro-oesophageal reflux and gastric 
emptying.  Following  this,  the effect  of  salivary  nitrite  on  the  post-prandial  gastro-
oesophageal  morphology  is  described.  Finally,  studies  examining  the  relationship 
between age and both the position and parietal cell density of the squamo-columnar 
junction are described.  3 
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Summary 
  Gastro-oesophageal  reflux  disease  (GORD)  is  the  commonest  chronic 
disease in Western countries. Symptomatic GORD is the strongest risk factor 
for the development of oesophageal adenocarcinoma with obesity and male 
sex also linked to the development of neoplasia at this site. Recent decades 
have seen a significant increase in the incidence of this highly lethal cancer 
among  Western  populations  with  Scotland  having  the  highest  recorded 
incidence worldwide. 
  Human  saliva  has  a  high  nitrite  content  derived  from  the  entero-salivary 
recirculation of nitrate in our diet which has resulted from the increased use of 
nitrogenous fertilisers over the past 50-60 years. 
  The  luminal  chemistry  produced  at  the  gastro-oesophageal  junction  (GOJ) 
when swallowed salivary nitrite reacts with gastric acid, and most notably the 
production  of  nitric  oxide  (NO),  may  explain  most  of  the  physiological 
abnormalities  that  contribute  to  the  pathogenesis  of  GORD.  NO  has  been 
shown  to  reduce  lower  oesophageal  sphincter  (LOS)  pressure,  impair 
oesophageal clearance, delay gastric emptying and may be the final mediator 
of  transient  lower  oesophageal  sphincter  relaxations  (TLOSRs).  Previous 
studies to investigate the role of this luminal chemistry in the pathogenesis of 
GORD show conflicting results. 
  In  addition  to  the  distal  oesophageal  acidification  produced  by  traditional 
trans-sphincteric reflux, previous studies suggest ‘splaying open’ of the distal 
lower oesophageal sphincter following a meal may expose the gastric cardia 20 
 
and the most distal oesophageal squamous mucosa to the noxious effects of 
gastric acid. 
  Although  the  gastric  cardia  is  an  important  site  of  pathology  in  the  upper 
gastrointestinal tract, it is a complex and poorly understood area. It has been 
proposed, from autopsy studies, that cardia mucosa itself may be pathological 
and  in  fact  an  ‘acquired  cardia’  due  to  metaplasia  of  the  most  distal 
oesophageal squamous mucosa. 
  A series of studies were designed to examine the effect of salivary nitrite on 
post-prandial GORD, gastro-oesophageal function and GOJ morphology in 20 
healthy, asymptomatic adult volunteers using high-resolution pH manometry, 
an  isotope  gastric  emptying  breath  testing  and  X-ray  localisation  of  the 
squamo-columnar junction (SCJ). 
  Despite an excellent range of salivary nitrite concentrations extending over 
and  above  the  normal  physiological  range  no  effect  of  salivary  nitrite  on 
gastro-oesophageal  reflux,  function  or  morphology  was  demonstrated. 
However,  the  studies  did  confirm,  for  the  first  time  using  high-resolution 
manometry, that distal opening of the LOS occurs after a meal. 
  The relationship of age and obesity to the SCJ position relative to the proximal 
border of the gastro-oesophageal high pressure zone (HPZ) was examined in 
15  Helicobacter  Pylori  negative  healthy  volunteers.  Strong  negative 
correlations were seen between SCJ position relative to the proximal HPZ and 
increasing  age,  body  mass  index  (BMI)  and  waist  circumference  (WC) 
respectively.  These correlations were stronger in the male sub-group. 21 
 
  In 25 healthy volunteers, parietal cell density was measured from endoscopic 
biopsies taken from  the macroscopic SCJ, 1cm distal to the SCJ, the gastric 
body and the gastric antrum. Again, a strong negative correlation was seen 
between increasing age and parietal cell density at the SCJ. This effect was 
localised to the SCJ and not seen at the other biopsy sites. 
  Our findings suggest that salivary nitrite does not alter gastro-oesophageal 
function, the integrity of the gastro-oesophageal barrier or gastro-oesophageal 
reflux  in  healthy  volunteers.  They  confirm  distal  opening  of  the  LOS  after 
meals. The strong negative correlations between age and both SCJ position 
relative to the proximal HPZ and parietal cell density support the hypothesis of 
an ‘acquired’ cardia. The development of cardia mucosa may also be linked to 
obesity, visceral obesity and male sex. 
  Future work could examine the carcinogenic effect of salivary nitrite and its 
luminal chemistry but this would require large scale epidemiological research. 
Further,  larger  clinical  studies  are  needed  to  investigate  the  role  of  distal 
opening  of  the  LOS  after  meals  and  to  improve  our  understanding  of  the 
gastric cardia. Such studies should focus on the role of obesity and posture. 22 
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Chapter 1 
An Introduction to Gastro-oesophageal Reflux Disease (GORD) 
 
1.1. Introduction 
Gastro-oesophageal  reflux  disease  (GORD)  is  the  commonest  chronic 
disease affecting Western populations. Heartburn and regurgitation are the cardinal 
symptoms of the disease (1) and pooled data from  studies suggest approximately 
25% have symptoms at least monthly, 12% have at least weekly symptoms and 5% 
suffer heartburn on a daily basis (2). 
GORD  is  generally  defined  as  the  reflux  of  gastric  contents  into  the 
oesophagus leading to  oesophageal inflammation (oesophagitis), reflux symptoms 
sufficient to impair quality of life, or long-term complications (3). While most people 
experience  some  physiological  gastro-oesophageal  reflux  after  meals,  such 
episodes are not usually associated with pathological signs or symptoms (4). GORD 
occurs  due  to  an  imbalance  between  the  protective  mechanisms  in  the  distal 
oesophagus  and  the  harmful  effects  of  refluxed  gastric  acid,  pepsin  and  bile  on 
oesophageal mucosa. 
 
1.2. The normal oesophagus and anti-reflux mechanisms 
The oesophagus is a muscular tube approximately 25cm long, composed of 
inner circular and outer longitudinal muscle layers. It is lined with stratified squamous 
epithelium.  The  tight  intercellular  junctions  of  these  squamous  cells  and  the 24 
 
production of a protective barrier of mucous and bicarbonate is designed to protect 
the epithelium from penetration by luminal molecules. However, unlike the columnar 
gastric mucosa, the squamous mucosa of the oesophagus is sensitive to damage 
from  the  highly  acidic  gastric  juice  (pH  2-3)  contained  in  the  stomach.  Digestive 
enzymes, such as pepsin, and duodenal juices, including bile, which are contained in 
the gastric juice may also damage squamous oesophageal mucosa. 
 A pressure gradient exists between the abdomen and thorax, exacerbated by 
the  negative  intra-thoracic  pressure  and  increased  intra-gastric  pressure  during 
inspiration and straining. To prevent reflux into the oesophagus of these potentially 
damaging  acidic  gastric  juices,  an  area  of  increased  pressure  must  exist  at  the 
gastro-oesophageal junction. This ‘high pressure zone’ is the primary mechanism of 
defence the human body has against gastro-oesophageal reflux. It consists of the 
lower oesophageal sphincter (LOS) and the crural diaphragm and crucially, not only 
does it provide an area of increased resting pressure, but it is able to compensate for 
the elevations in intragastric pressure produced during inspiration and straining. 
The LOS, or intrinsic sphincter, is a section of specialized smooth muscle in 
the distal oesophagus of approximately 4cm in length. LOS tone is thought to be 
maintained by excitatory neurones with cholinergic innervations which are under the 
control of the vagus nerve (5;6). In healthy individuals, the LOS tonically contracts, 
closing  the  distal  oesophageal  lumen  and  maintaining  a  pressure  of  at  least 
15mmHg above intra-gastric pressure (7). The sphincter is able to relax in response 
to  oesophageal  peristalsis  to  allow  the  passage  of  food,  liquid  or  saliva  into  the 
stomach. This LOS relaxation is mediated by nitric oxide (NO) (8). 25 
 
The human diaphragm is composed of two parts with separate embryological 
origins. The costal diaphragm originates from the ribs, while the crural diaphragm is 
attached to the vertebral column. The crural diaphragm encircles the proximal 2cm of 
the  LOS.  By  contracting  on  inspiration  and  during  straining,  it  augments  LOS 
pressure  and  helps  prevent  reflux.  However,  studies  also  demonstrate  that  it 
prevents reflux during periods of absent LOS pressure, underlining its importance as 
an  anti-reflux  barrier  (9;10).  As  a  result,  it  is  often  referred  to  as  the  ’extrinsic 
sphincter’. In common with the rest of the diaphragm, the crura are innervated by the 
phrenic nerve. However, the crura contract a fraction of a second earlier than the 
costal diaphragm (11). This may be physiologically important to its role as an anti-
reflux barrier, ensuring that pressure at the gastro-oesophageal junction increases 
before  alterations  in  the  gastro-oesophageal  pressure  gradient  incurred  by 
inspiration or straining. 
The gastric sling fibres (oblique fibres) are located below the LOS and are 
also thought to contribute to the anti-reflux barrier.  Muscle fibres are arranged on 
the greater curvature of the stomach with a gap in the fibres across the lesser curve. 
Due to this arrangement, pressure in the gastric fundus creates a flap that presses 
against the lower end of the oesophagus, again augmenting LOS pressure during 
periods of increased intra-gastric pressure. As a result, this area has been described 
as the gastro-oesophageal ‘flap valve’ (12). 
Once  gastric  contents  reflux  into  the  oesophagus,  rapid  clearance  of  the 
refluxate  must  occur  to  prevent  damage  to  the  squamous  oesophageal  mucosa 
which is vulnerable to its noxious mixture of gastric acid, pepsin and bile. The normal 
mechanism  of  clearance  is  a  two-stage  process.  Firstly,  there  is  clearance  of 26 
 
refluxate volume by peristalsis. Peristalsis is a wave of oesophageal circular muscle 
contraction that propagates down the oesophagus to the level of the LOS and may 
be primary or secondary. Primary peristalsis is voluntary and occurs approximately 
60  times  per  hour.  During  primary  peristalsis,  circular  muscle  contraction  is 
accompanied by longitudinal muscle contraction which shortens the oesophagus by 
2-2.5cm  (13;14).  Secondary  peristalsis  occurs  without  a  pharyngeal  swallow  and 
may be provoked by distal oesophageal distension or acidification, both of which can 
occur during episodes of gastro-oesophageal reflux (15). During a reflux episode, 
one or two peristaltic waves will empty the distal oesophagus and only a fraction of 
the refluxate will persist. Residual acid can then be neutralized by swallowed saliva 
(16). The normal gastro-oesophageal anatomy and relevant anti-reflux structures are 
shown in Figure 1.1 
 
1.3. The pathophysiology of GORD 
A minority of GORD patients (20%) will have, as their primary disorder, LOS 
incompetence. This is either due to reduced resting LOS pressure, increased intra-
abdominal pressure (e.g. secondary to obesity or pregnancy) or shortening of the 
LOS (15). Acid exposure in such patients is prolonged, especially when supine, and 
severe GORD with complications is often found (17). 
However,  many  patients  with GORD  have a  normal resting  LOS  pressure. 
This apparent contradiction was explained by Dodds et al who discovered that the 
majority of reflux events in both healthy volunteers (18) and reflux patients (19) occur 
during  transient  lower  oesophageal  sphincter  relaxations  (TLOSRs).  TLOSRs  are 27 
 
defined manometrically as sudden, prolonged relaxations of the LOS not associated 
with swallowing (20). Gastric distension is a potent stimulus for the production of 
TLOSRs and studies have shown that distension with free air (21), a balloon (22) 
and, more importantly, a meal (23) all result in an immediate increase in TLOSRs. 
This  helps  to  explain  the  increase  in  reflux  events  which  occurs  post-prandially. 
Significantly, during TLOSRs, the activity of the crural diaphragm is also inhibited (9), 
facilitating free reflux of gastric contents into the distal oesophagus. 
The  neural  pathways  underlying  TLOSRs  are  now  partly  understood.  By 
dividing  the  stomach  into  separate  compartments,  Franzi  et  al  (24)  were  able  to 
demonstrate that the cardia region has the lowest threshold for triggering TLOSRs. 
Furthermore, inhibition of the vagal nerve by cooling abolishes TLOSR production, 
suggesting  a  vago-vagal  reflex  (25).    The  afferent  pathway  in  this  reflex  arc  is 
therefore  thought  to  consist  of  vagal  afferents  within  the  muscle  layers  of  the 
proximal  stomach,  sensitive  to  stretching  during  gastric  distension  (26).  These 
afferent  fibres  terminate  in  the  nucleus  tractus  solitarius  and  the  dorsal  motor 
nucleus  of  the  vagal nerve in  the  brainstem  (27-29).  From  here,  motor  neurones 
project to the enteric nervous system of the LOS (30). 
It would be assumed that GORD patients would have higher rates of TLOSRs 
but TLOSRs are not more frequent in GORD patients, simply a higher proportion are 
accompanied  by  reflux  (31).  However,  the  mechanisms  behind  this  are  poorly 
understood. 
As  previously  described,  the  gastro-oesophageal  ‘high  pressure  zone’,  the 
primary  anti-reflux  barrier,  consists  of both  the  LOS  and  the  crural diaphragm.  A 
hiatus  hernia  occurs  from  spatial  separation  of  these  normally  overlapping  and 28 
 
complimentary structures with the proximal stomach migrating above the level of the 
diaphragm in the thorax. This is a common endoscopic and radiological finding in 
patients with GORD. A large hiatus hernia certainly predisposes to GORD (32) and 
is associated with an increased risk of oesophagitis (33). Not only does it result in a 
reduction in peak LOS pressure (34) but the presence of a hiatus hernia predisposes 
to  increased  rates  of  TLOSRs  (35),  interferes  with  primary  peristalsis  leading  to 
inadequate clearance of refluxate (36) and provides an opportunity for accumulation 
of gastric contents in the hiatal sac, facilitating reflux during swallow-induced LOS 
relaxations (37). Finally, in patients with a hiatus hernia, the absence of the gastro-
oesophageal flap valve and loss of an intra-abdominal portion of the oesophagus 
may also contribute to reflux (38). 
An unbuffered ‘pocket’ of acid in the proximal stomach and cardia region has 
also been described after a meal (39). Studies have shown it to be enlarged in reflux 
patients  compared  with  health  volunteers  (40)  and  it  may  contribute  to  distal 
oesophageal exposure post-prandially (41). 
Several  studies  have  examined  the  influence  of  solid  and  liquid  gastric 
emptying on GORD with conflicting results. Some studies show high rates of delayed 
gastric emptying in GORD patients compared to healthy controls  (42;43) while in 
others (44-46) rates are equivalent. However, it is likely that in a small number of 
GORD patients delayed gastric emptying contributes both by increasing the amount 
of fluid available for reflux post-prandially and by increasing the rate of TLOSRs due 
to an associated increase in gastric distension. 
Lifestyle factors and drugs may contribute towards the pathogenesis of GORD 
by causing reduced LOS pressures or inappropriate relaxation of the LOS. Obesity 29 
 
leads  to  increased  intra-abdominal  pressure  increasing  the  gradient  across  the 
gastro-oesophageal ‘high pressure zone’. As a result it may disrupt the LOS (47), it 
may also lead to the development of a hiatus hernia due to mechanical pressures on 
the diaphragm  and may increase the number of TLORSs (48). Systematic reviews 
(49) suggest an association between increased body mass index (BMI >25kg/m
2) 
and reflux symptoms (OR 1.43) while a similar association is seen with the risk of 
oesophagitis (OR 1.76).  Many drugs (e.g. anticholinergics) reduce LOS pressure 
and  similar  effects  are  produced  by  smoking  (50),  alcohol  (51),  coffee  (52)  and 
chocolate  (53).  Fatty  meals  reduce  LOS  pressure  as  a  result  of  increased  CCK 
release in response to duodenal fat, can cause delayed gastric emptying and are 
also associated with increased rates of TLOSRs (22;54;55). 
 
1.4 Complications of GORD 
In addition to the typical symptoms of heartburn and regurgitation, GORD may 
be  associated  with  more  serious  complications.  Inflammation  of  the  oesophagus 
(oesophagitis)  can  occur  and  ranges  from  mild  erythema  to  the  development  of 
erosions and ulceration. More severe ulceration can progress to the formation of a 
peptic stricture and obstruction of the oesophagus. Barrett’s oesophagus is defined 
as  a  metaplastic  change in  the oesophageal  squamous  mucosa  to  a  specialized 
intestinal epithelium and occurs as a consequence of longstanding GORD (56). It is 
recognized  as  a  premalignant  condition  and  studies  estimate  the  excess  risk  of 
oesophageal adenocarcinoma to be increased 30 to 60 fold relative to the general 
population risk (57-60). However, the actual risk of oesophageal adenocarcinoma 
may be as low as 0.4% per year (61). 30 
 
Symptomatic  gastro-oesophageal reflux  is recognized  as  the  strongest  risk 
factor  for  the  development  of  oesophageal adenocarcinoma.  A  large  case-control 
study by Lagergren et al (62) found that the risk of oesophageal adenocarcinoma 
was  nearly  eight  times  higher  in  those  experiencing  symptoms  of  heartburn  or 
regurgitation at least weekly than in asymptomatic individuals. Symptoms of reflux at 
night  were  associated  with  an  almost  11-fold  increased  risk.  Oesophageal 
adenocarcinoma continues to be a highly lethal cancer with 5-year survival rates of 
only approximately 10% across Europe (63).  
 
1.5 Recent changes in upper gastrointestinal cancer epidemiology 
The past four decades have seen a significant increase in the incidence of 
oesophageal  adenocarcinoma  among  Western  populations  (64)  with  Scotland 
having the highest recorded incidence worldwide (65). In contrast, the incidence of 
carcinoma of the mid and distal stomach has progressively fallen (66).  
Recent data from the Scottish Cancer Registry (2011) show that the incidence 
of  oesophageal  adenocarcinoma  has  increased  by  approximately  250%  over  the 
past 25 years, from a total of 179 cases in 1985 to 449 cases in 2009  – annual 
incidence  rates  of oesophageal  adenocarcinoma  are  shown  in  Figure  1.2.  At  the 
same  time  there  has  been  a  43.5%  reduction  in  the  number  of  cases  of  gastric 
cancer diagnosed, from 1328 in 1985 to 750 in 2008 – annual incidence rates of 
gastric cancer are shown in Figure 1.3. The 5-year survival rate in Scotland is only 
10.8%. 31 
 
The falling incidence of non-cardia gastric cancer may be explained by the 
falling incidence of Helicobacter pylori infection since Helicobacter pylori associated 
atrophic gastritis is a major risk factor for cancer at these site. Debate exists as to 
the aetiology of the increasing incidence of oesophageal adenocarcinoma but the 
reduction in Helicobacter pylori infection has also been proposed as an explanation 
for the increasing incidence of adenocarcinoma of the distal oesophagus. In earlier 
generations, acid secretion would diminish with increasing age due to Helicobacter 
pylori-induced  gastric  atrophy.  However,  Helicobacter  pylori  negative  individuals 
maintain their ability to secrete gastric acid throughout their life with the potential for 
greater  oesophageal acid  exposure as  a  result.  An additional explanation  for  the 
increase in distal oesophageal adenocarcinomas is the potential carcinogenic and 
refluxogenic effect of reactive nitrogen species generated at this anatomical site. 
 
1.6 Summary 
In  summary,  GORD  is  a  common  chronic  condition.  Its  aetiology  is  multi-
factorial and not fully understood. It is not only a significant burden on healthcare 
systems in terms of cost but causes significant morbidity and can be associated with 
more  serious  complications  including  oesophagitis,  peptic  strictures,  Barrett’s 
oesophagus  and,  ultimately,  oesophageal  adenocarcinoma.  The  incidence  of 
oesophageal  adenocarcinoma  continues  to  rise,  especially  in  our  own  country, 
where  rates  are  the  highest  recorded  globally.  The  cause  for  this  increase  in 
incidence remains to be confirmed. 32 
 
 
Figure 1.1 The normal oesophagus and gastro-oesophageal junction 
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Figure 1.2. Incidence of oesophageal adenocarcinoma in Scotland (1985 -2009) 
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Figure 1.3. Incidence of gastric cancer in Scotland (1985 -2009) 34 
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Chapter 2 
The Salivary Nitrite Hypothesis 
 
2.1 Salivary nitrite production from dietary nitrate 
Human saliva has a high nitrite concentration, derived from the entero-salivary 
recirculation of nitrate. Once it is ingested, nitrate is absorbed into the bloodstream 
from the small intestine and supplemented by a small amount of endogenous nitrate. 
Entero-salivary recirculation results in 25% of this nitrate being actively secreted by 
the salivary glands (67). Bacteria in the mouth then enzymatically convert between 
10 and 90% of this nitrate in saliva to nitrite (68). The production of nitrite from the 
entero-salivary recirculation of dietary nitrate is illustrated in Figure 2.1 
Nitrate is  present in  substantial  amounts  in  the  modern  diet and is  mainly 
derived from nitrogenous fertilisers (69). Intensive farming, such as the growing of 
vegetables  in  low  light  intensity  but  high  temperature  glasshouses,  also  leads  to 
increased  nitrate  concentrations  (70).  The  use  of  nitrogenous  fertiliser  began  to 
increase in Western countries from the  middle of the 20
th century (71) leading to 
increased nitrate deposition in soil. An increase in intensive farming techniques was 
seen at the same time. Following its uptake from the soil, nitrate is reduced to the 
ammonium ion (NH4+) and then incorporated rapidly into organic compounds by the 
plant. Leaching of fertiliser subsequently leads to a gradual increase in groundwater 
nitrate concentrations. As a result, the main sources of nitrate in the human diet are 
green  leafy  vegetables  (such  as  lettuce  and  spinach),  root  vegetables  (such  as 
beetroot and potatoes) and water. 36 
 
In  the  past  few  decades,  increasing  public  health  concerns  developed 
regarding the association between nitrate and infantile methaemoglobinaemia (72) 
and the possible association between nitrate and gastric cancer (73). This prompted 
the introduction of regulations to reduce nitrate-based fertiliser use and limit nitrate 
concentrations  in  food  and  water.  In  1990,  the  European  Commission's  (EC) 
Scientific Committee for Food (SCF) set an Acceptable Daily Intake (ADI) for the 
nitrate ion of 3.65 mg/kg body weight (equivalent to 219 mg/day for a 60 kg adult) 
(74). As a result of these measures, the use of nitrogenous fertilisers has plateaued 
towards the end of the 20
th century in most Western countries (75). 
 
2.2 Gastric acidification of nitrite and its carcinogenic potential 
When  nitrite is  swallowed  it  reacts  with  acidic  gastric  juice  forming  nitrous 
acid, the nitrosating species N2O3, NOSCN and by further reaction with ascorbic acid 
in gastric juice it is also converted to nitric oxide (NO). Nitrosating species are able to 
react  with  secondary  amines  and  amides  in  gastric  juice  to  form  N-nitroso 
compounds (76). The endogenous production of these compounds is of interest due 
to their ability to induce cancer in animal models (77). Furthermore nitric oxide is 
itself known to be mutagenic at high doses. 
Previous work by Moriya et al (78) using a model to simulate the interaction of 
salivary nitrite and gastric acid suggested the gastro-oesophageal junction to be the 
anatomical  site  of  maximal  acid  catalysed  generation  of  N-nitroso  compounds 
following a nitrate load. Subsequently, using a luminal nitric oxide sensor, Iijima et al 
(79)  demonstrated  maximal  generation  of  nitric  oxide  at  the  gastro-oesophageal 37 
 
junction  in  normal  healthy  volunteers  following  nitrate  ingestion.  Similar  work  by 
Suzuki  et  al  using  microdialysis  probes  defined  the  anatomical  location  where 
chemical conditions favouring the acid catalysed generation of N-nitroso compounds 
was maximal. In normal volunteers this occurred at the level of the gastric cardia (80) 
while in Barrett’s oesophagus, the maximal potential for nitrosation was found within 
the Barrettic segment itself (81). Therefore, in both normal volunteers and Barrett’s 
patients  the  anatomical  location  of  maximal  acid  catalysed  luminal  nitrosation 
corresponds  to  the  interface  between  saliva  and  gastric  acid.  Winter  et  al 
subsequently  demonstrated  the  in  situ  formation  of  N-nitrosocompounds  from 
ingested dietary nitrate via NO formation. During episodes of reflux this occurred 
almost exclusively in the oesophagus (82). 
These  studies  support  the  hypothesis  that  nitric  oxide  and  N-nitroso 
compounds  generated  from  salivary  nitrite  may  be  implicated  directly  in 
carcinogenesis at the gastro-oesophageal junction and within the distal oesophagus. 
However, they may also have a contributory role in potentiating gastro-oesophageal 
reflux disease. 
 
2.3. Salivary nitrite in the pathogenesis of GORD 
In  addition  to  its  mutagenic  potential,  excessive  production  of  nitric  oxide 
could explain  most of the functional abnormalities associated with reflux disease. 
Nitric oxide is well recognised to induce smooth muscle relaxation, by elevation of 
tissue cyclic guanosine monophosphate (cGMP) levels (83), and a number of studies 
have described the effects of NO on upper gastrointestinal motility. 38 
 
In vitro studies by Tottrup at al (84) on opossum lower oesophageal sphincter 
demonstrated  that  N-nitro-L-arginine  (L-NNA)  a  substance  known  to  inhibit  NO 
formation  inhibited  lower  oesophageal  sphincter  relaxation.  This  effect  was 
attenuated by the NO substrate L-arginine. A similar study by Preksaitis et al (85) 
examining human lower oesophageal sphincter muscle, which also used L-NNA to 
inhibit NO, indicated that the same process was most likely involved in man. 
The effect of NO on the production of TLOSRs has also been studied. Boulant 
et al (55) described a reduction in TLOSRs induced by gastric distension in dogs 
following  infusion  of  the  NO  synthase  inhibitor  N-nitro-L-arginine-methyl-ester  (L-
NMME). Again, this effect was reversed by L-arginine. Hirsch et al (86) confirmed 
this effect on healthy, human volunteers undergoing oesophageal manometry also 
using gastric distension by balloon insufflation as the trigger for TLOSRs. L-NMMA 
or  placebo  was  given  in  a  randomised,  double-blinded  fashion  and  significantly 
inhibited the increase in TLOSRs brought about by gastric distension. A further study 
by  Hirsch  et  al  (87)  looking  at  the  physiological  induction  of  TLOSRs  by  meal-
induced gastric distension concluded that L-NMME infusion also inhibited TLOSRs 
post-prandially and reduced the total number of reflux episodes. 
L-NMME has been found to reduce oesophageal peristalsis in animal models. 
A  study  by  Anand  et  al  (88)  using  adult  opposums  demonstrated  a  reduction  in 
swallow  induced  contraction  amplitude  in  the  distal  oesophagus  following  NO 
synthase inhibition. Studies in man using Sildenafil support the involvement of NO in 
oesophageal  peristalsis.  Sildenafil  blocks  type  5  phosphodiesterase  (PD5)  which 
destroys NO stimulated cGMP. Rhee et al (89) performed oesophageal manometry 
on healthy volunteers before and after infusion of 50mg sildenafil directly into the 39 
 
stomach.  Oesophageal  body  peristaltic  amplitudes  gradually  decreased  and  were 
subsequently abolished with a corresponding increase in peristaltic latency. Eherer 
et al (90) confirmed this in a randomised and double-blinded study of 50mg sildenafil 
or  placebo  given  to  healthy  volunteers  and  patients  with  oesophageal 
hypercontractility  disorders.  Reduced  oesophageal  body  propulsive  forces  were 
observed  in  both  groups.  Both  these  studies  also  confirmed  a  reduction  in  LOS 
pressure  following  sildenafil.  Similarly,  increasing  NO  bioactivity,  by  inhibiting 
phosphodiesterase, enhances gastric accommodation and delays gastric emptying 
(91). 
Nitric oxide has therefore been demonstrated to lower the tone of the LOS, 
may  impair  oesophageal  acid  clearance  through  its  effects  on  peristalsis,  delays 
gastric emptying and is known to be the final mediator in the production of TLOSRs. 
However, can these effects be demonstrated post-prandially following an oral nitrate 
load?  
 
2.4. Previous Studies 
Bove  et  al  (92)  combined  pH  and  manometry  studies  on  both  healthy 
volunteers  and  GORD  patients  following  dietary  nitrate  supplementation.  All 
volunteers received a nitrate deprived diet and were randomised to either potassium 
nitrate 200mg or placebo for 4 days with a two week wash-out period in between. 
They reported no significant effect on oesophageal reflux or oesophageal motility 
following  nitrate  supplementation.  However  there  was  a  strong  trend  towards  an 
increase  in  TLOSRs in  the  group  receiving  nitrate  supplementation.  Significantly, 40 
 
salivary  nitrite  concentrations  in  the  study  were  well  below  the  levels  that  have 
regularly been described in studies by our own group (79). In contrast, by infusing 
nitrous acid and nitric oxide forming solutions directly into the distal oesophagus after 
a standardised meal, Manning et al (93) demonstrated that chemicals formed from 
the  gastric  acidification  of  salivary  nitrite  can  influence  oesophageal  and  gastric 
function  which  may  be  relevant  to  GORD. Using  combined  oesophageal  pH and 
manometry  studies  they  reported  a  reduction  in  LOS  pressure  and  increase  in 
frequency of TLOSRs post-prandially following infusion of the nitric oxide generating 
infusion. They also described an attenuation of the post-prandial increase in intra-
gastric pressure following the nitrous acid infusion, possibly due to delayed gastric 
emptying. 
 
2.5. Summary 
Human  saliva  has  a  high  nitrite  concentration  from  the  entero-salivary 
recirculation  of  dietary  nitrate.  Swallowed  nitrite  reacts  with  gastric  acid  to  form 
nitrous  acid,  nitrosating  species  and  nitric  oxide  (NO)  at  the  gastro-oesophageal 
junction.  In  addition  to  being  potentially  mutagenic  and  carcinogenic,  this luminal 
chemistry  and  in  particular  the  generation  of  NO,  might  contribute  to  the 
pathogenesis of reflux disease. NO has been shown to reduce lower oesophageal 
sphincter (LOS) pressure, impair oesophageal clearance, delay gastric emptying and 
may be the final mediator in the production of transient lower oesophageal sphincter 
relaxations (TLOSRs). Existing studies that examine the effect of  altering the luminal 
nitrite  chemistry  on  gastro-oesophageal  motility  and  whether  or  not  this  may 
potentiate  gastro-oesophageal  reflux  show  conflicting  results.41 
 
 
Figure 2.1. The entero-salivary recirculation of dietary nitrate (adapted from McColl KEL 
Gut 2005;54:1-3) 
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3.1. Oesophageal histology 
The oesophagus is lined by non-keratinized stratified squamous epithelium 
with an average thickness of 500-800µm. The basal layer consists of cuboidal or 
rectangular  cells  and  may  be  several  cell  layers  thick,  also  containing  scattered 
melanocytes  and  neuroendocrine  cells.  Above  this, epithelial  cells  are larger  and 
become more flattened as they approach the oesophageal lumen. 
The oesophageal lamina propria is comprised of loosely arranged collagen 
fibres  and  fibroblasts  embedded  within  an  acellular  matrix,  with  a  scattering  of 
lymphocytes, eosinophils, mast cells and plasma cells. The muscularis mucosa is of 
variable thickness, being thicker at its distal end where it approaches the GOJ. 
Mucous glands are present within the oesophageal submucosa. Each gland 
has between 2 and 5 lobes, which drain into a short duct lined by stratified columnar 
epithelium.  These  ducts  penetrate  the  muscularis  mucosa,  lamina  propria  and 
epithelium to open into the oesophageal lumen, allowing secretion of bicarbonate 
and mucous which help lubricate the oesophagus and protect against acid-related 
mucosal damage. Around the glands and their ducts, lymphocytes, plasma cells and 
eosinophils can be found while the oesophageal submucosa is also rich in blood 
vessels, lymphatics and ganglion cells. 
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3.2. Gastric histology 
A  key  role  of  the  gastric  epithelium  is  to  secrete  hydrochloric  acid  and 
proteolytic enzymes to aid in the digestion of food. As a result, the gastric mucosa 
must be designed to withstand the effects of these potentially corrosive substances. 
The  stomach  also  secretes  mucous  which  lubricates  food  and  helps  protect  the 
gastric mucosa from acid and pepsin. These secretions are produced from 3 main 
cell types: 
  Mucous cells 
  Acid-producing cells (oxyntic or parietal cells) 
  Enzyme-producing cells (Chief or peptic cells) 
 
In addition, there is a population of hormone-secreting enteroendocrine cells 
and stem cells from which other cell types are derived. 
  Gastric  mucous  cells  are  of  2  types.  Surface  mucous  cells  are  tall  and 
columnar.  Neck  mucous  cells  are  smaller  and  less  regular  in  shape,  being 
compressed and distorted by adjacent cells.  
The acid-secreting parietal cells are large pyramidal cells. The capacity of the 
stomach to secrete hydrochloric acid (HCl) is linearly related to parietal cell numbers. 
Parietal cells have a vast luminal surface area as a result of deep microvilli-lined 
invaginations  called  canaliculi.  When  stimulated,  parietal  cells  secrete  HCl  at  a 
concentration of approximately 160 millimoles (equivalent to  a pH of 0.8). Acid is 
secreted into  the  canaliculi  by  a  process  of  active transport  via  the  H
+K
+ATPase 
proton pumps located in the canalicular membrane. Hydrogen ions are generated 45 
 
within the parietal cell from the dissociation of water. Carbon dioxide diffuses across 
the basement membrane from blood capillaries into the cell where it links with water 
molecules. This reaction, which is catalysed carbonic anhydrase, produces carbonic 
acid (H2CO3) which immediately dissociates into a H
+ ion and HCO3
- ion. The latter 
passes back into the blood while the H+ is pumped into the lumen via the canaliculi. 
Chloride ions are also actively transported across the cells into the canaliculi from 
capillaries in the lamina propria. 
 
3.3. The histology of the gastric cardia 
The  gastric  cardia  is  grossly  defined  anatomically  as  the  area  extending 
distally from the squamo-columnar junction at the lower end of the oesophagus into 
the proximal stomach. Conventional medical teaching states that cardiac mucosa is 
normally  present  in  humans  and  extends  a  length  of  2-3  centimetres.  Cardiac 
mucosa has been defined histologically as mucosa in this region composed only of 
mucous  cells.  It  is  therefore  distinct  from  the  oxyntic  mucosa  typically  seen 
elsewhere in the stomach which contains additional parietal cells and goblet cells. 
The endoscopic appearance (A) and histology (B) of the normal gastro-oesophageal 
junction are seen in Figure 3.1. 
Cardiac  mucosa  is  recognized  as  an  area  with  a  high  incidence  of 
inflammation, metaplasia and neoplasia. Oberg et al (94) studied patients with reflux 
symptoms or dyspepsia and found cardiac mucosa to be inflamed in 96%. Similarly 
Der et al (95) examined biopsied the cardia region in 141 patients. In all patients, 
cardiac  mucosa  showed  significant  chronic  inflammation  with  79%  of  patients 46 
 
showing  no  evidence  of  gastritis  on  biopsies  from  the  gastric  antrum  and  body. 
Upper  gastrointestinal  endoscopy  screening  of  patients  attending  for  lower 
gastrointestinal endoscopy has also demonstrated the high prevalence of disease in 
this area. Gerson et al (96) performed upper gastrointestinal endoscopy and biopsy 
on 110 subjects attending for sigmoidoscopy as screening for colorectal cancer. In 
16% of patients, intestinal metaplasia was found at the gastric cardia. Likewise, Rex 
et al (97) examined 961 patients attending for colonoscopy and found the detection 
rate of intestinal metaplasia at the gastric cardia to be 12.9%. 
 
3.4. The ‘acquired cardia’ hypothesis 
Despite the high rate of pathology at the gastric cardia, this complex area is 
poorly understood. Indeed controversy exists as to whether cardiac mucosa itself 
may  be  pathological.  Previous  autopsy  studies  show  a  near  absence  of  cardia 
epithelium  in  neonates  and  an  increase  in  length  with  increasing  age  (98;99). 
Similarly,  in  thoroughly  sampling  the  squamocolumnar  junction  of  endoscopically 
normal patients, Jain et al (100) and Marsman et al (101) reported an absence of 
cardiac mucosa in 65% and 38% respectively. Furthermore, in the study by Oberg et 
al  (94),  of  the  334  patients  studied  only  246  (74%)  were  found  to  have  cardiac 
mucosa while 88 (26%) did not. Those with cardiac mucosa were more likely to have 
abnormal  acid  exposure  on  24  hour  pH  testing  and  were  more  likely  to  have 
abnormalities of the LOS manometrically. They concluded this was proof that cardiac 
mucosa  is  in  fact  an  abnormal  structure.  They  suggest  it  originates  from  acid-
induced columnar metaplasia of the most distal oesophageal squamous mucosa with 
the only normal gastro-oesophageal mucosa being squamous oesophageal mucosa 47 
 
and oxyntic gastric mucosa. It should be noted that Helicobacter-associated atrophy 
of the proximal gastric mucosa could cause a similar effect. 
Although 30-50% of upper gastrointestinal tract adenocarcinomas occur at the 
gastro-oesophageal  junction  (GOJ)  or  gastric  cardia  (66),  unlike  oesophageal 
adenocarcinoma,  the  association  of  these  cancers  with  symptomatic  gastro-
oesophageal reflux disease is weak (62). Studies using both 24 hour ambulatory pH 
monitoring and intraluminal impedance have shown a positive association between 
the    proximal  extent  of  reflux  episodes  and  the  perception  of  heartburn  and 
regurgitation, the cardinal symptoms of reflux disease (102-105). 
 
3.5. Distal opening of the lower oesophageal sphincter after meals 
In  studies  using  pull  through  pH  and  manometry,  our  own  group  have 
observed post-prandial shortening of the LOS. In studies by both Manning et al (93) 
and subsequently Clarke et al (40), this shortening was found to result from a loss of 
the distal segment of the lower oesophageal sphincter (LOS) with the pH step-up 
point moving closer to or even across the squamocolumnar junction (SCJ).  
Fletcher  et  al  had  previously  described  an  unbuffered  postprandial  ‘acid 
pocket’  occurring  in  the  proximal  stomach  of  healthy  subjects  after  meals  and 
observed  that  it  extends  across  the  SCJ  into  the  distal  oesophagus  (39).  The 
presence of a postprandial acid pocket in both healthy subjects and reflux patients 
was confirmed in the study by Clarke et al who found the ‘acid pocket’ to be located 
within the abdominal portion of the HPZ which ‘opens’ after a meal.  48 
 
Therefore,  this  ‘distal  opening’,  which  was  first  postulated  by  Oberg  and 
DeMeester  (94;106),  may  result  in  acidification  of  the  most  distal  oesophageal 
squamous mucosa without complete loss of function of the LOS. Due to the limited 
proximal extent of acid exposure, such a process is likely to be asymptomatic and 
may  explain  the  high  incidence  of  pathology  at  the  GOJ  of  otherwise  ‘healthy’ 
subjects. 
 
3.6. Summary 
The  gastric  cardia  and  gastro-oesophageal  junction  is  an important  site  of 
pathology  in  the  gastrointestinal  tract  with  a  high  incidence  of  inflammation, 
metaplasia and neoplasia even in asymptomatic people. It has been suggested that 
cardia  mucosa  itself  may  be  pathological  and  represent  acid-induced  columnar 
metaplasia  of  the  most  distal  oesophageal  squamous  mucosa.  A  possible 
mechanism  for  this  could  be  distal  opening  of  the  LOS  after  meals  in  healthy 
subjects,  exposing  the  distal  oesophagus  to  the  unbuffered  post-prandial  ‘acid 
pocket’. 49 
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4.1 The global obesity epidemic 
In  recent  years  global  rates  of  obesity  have  dramatically  increased, 
particularly in Western countries. As a result, healthcare systems are now dealing 
with what many describe as an epidemic of obesity and its complications, such as 
diabetes, heart disease and fatty liver disease. 
The World Health Organisation (WHO) estimates that worldwide there are 1.7 
billion people overweight (BMI ≥ 25 ≤ 30) while 300 million have a BMI >30 and 
would be classified as obese (107) according to the current WHO classification – see 
Table 4.1. 
 
4.2. A Scottish perspective 
In  Scotland,  a  recent  national  survey  (108)  found  that  obesity  rates  have 
increased significantly over the past two decades. In adults between the ages of 16 
and 64 years old, the percentage of men who are overweight or obese has risen 
from 55.6% in 1995 to 66.3% in 2009. A similar increase, from 47.2% to 58.4%, is 
seen among women while rates of morbid obesity (BMI > 40) have trebled from 0.5% 
to 1.8% and 1.3 to 3.6% in men and women respectively between 1995 and 2009. 
Measures of central, or visceral, obesity such as waist circumference or waist-to-hip 
ratio show similar increases over this period. 52 
 
4.3. The rising Incidence of GORD 
An increase in reflux disease has also been seen among Western populations 
over recent decades. A North American study by El-Serag et al (109) reported a four 
to seven-fold increase in presentations with reflux disease between 1970 and 1995. 
As a result, GORD is now the commonest chronic disease in Western populations. 
This raises the question of whether this increase in GORD can be explained due to 
the concomitant increase in obesity rates among the population? 
 
4.4. The epidemiological link between obesity and GORD 
Numerous studies have examined the link between obesity and GORD with 
almost  all  showing  a  significant  association  between  obesity,  measured  by  BMI, 
waist  circumference  or  waist-to-hip  ratio,  and  both  the  frequency  and  severity  of 
reflux symptoms. This effect appears to be independent of differences in diet and 
exercise (110) and has been confirmed in two meta-analyses (49;111) 
The  largest  epidemiological  study  to  investigate  this  association  was 
performed by Jacobson et al (112). Using a questionnaire, the authors investigated 
the frequency, severity and duration of symptoms of GORD among 10,545 randomly 
selected participants in the Nurses’ Health Study. 2310 subjects (22%) had weekly 
symptoms of heartburn, acid regurgitation or both. They observed a dose-dependent 
relationship between increasing BMI and frequent reflux symptoms. Similar findings 
were  documented  when  waist  circumference  was  examined.  Furthermore,  in  the 
group  with  a  normal  baseline  BMI,  an  increase  in  BMI  of  greater  than  3.5  was 
associated  with  an  increased  risk  of  frequent  reflux  symptoms  (OR  2.8)  when 53 
 
compared  with no weight gain. These results support the hypothesis that obesity 
increases the risk of GORD and suggest that even moderate weight gain in subjects 
of normal weight may cause or exacerbate reflux symptoms. 
In the United Kingdom, similar work by Murray et al (113) studied 10,537 adult 
subjects as part of the Bristol Helicobacter Project. They confirmed this association 
in  our  own  population,  finding  that  overweight  subjects  were  at  increased risk  of 
suffering  GORD  symptoms.  The  adjusted  odds  ratios  for  overweight  subjects  of 
suffering symptoms of heartburn and regurgitation were 1.82 and 1.5 respectively 
while the corresponding OR for obese subjects were 2.91 and 2.23. 
The  risk  of  reflux  oesophagitis  is  also  increased  in  overweight  and  obese 
subjects. In a study of 1224 Scandinavian patients referred for upper GI endoscopy, 
Stene-Larsen et al found that obesity, measured using the weight for height index, 
was associated with an increased risk of reflux oesophagitis (114). Following on from 
this, El-Serag et al found that obesity was an independent risk factor for severe (Los 
Angeles Grade C or D) oesophagitis with an OR of 1.21 (115). 
These results clearly suggest an increased risk of both GORD symptoms and 
clinical manifestations in overweight and obese adults. 
An interesting addition to the current evidence supporting this association is a 
randomised trial by Fletcher et al from our own group  (116). In this study, which 
examines factors predicting response to proton pump inhibitor (PPI) therapy, 105 
Helicobacter  Pylori  negative  subjects  with  upper  gastrointestinal  symptoms  but 
normal endoscopy were randomised to two weeks of treatment with PPI or placebo. 
Symptom severity scores were calculated before and during treatment with PPI or 54 
 
placebo.  Anthropometric  measurements,  24  hour  oesophageal  pH  studies  and 
oesophageal  manometry  were  also  performed  prior  to  randomisation.  The 
investigators found that the only non-invasive predictor of response to PPI treatment 
was a patient’s BMI. The BMI was noted to have a similar predictive value to 24h 
oesophageal pH or manometry suggesting a strong association between BMI and 
underlying reflux disease. 
 
4.5. Mechanisms by which obesity may precipitate GORD 
The  epidemiological  data  clearly  points  to  a  significant positive  association 
between obesity and GORD but if this is true, how does obesity lead to GORD? 
A host of dietary and lifestyle factors relating to obesity share a common link 
to GORD but the effect of obesity has been shown to be independent of diet and 
exercise.  It  was  previously  suggested  that  obese  patients  may  have  a  greater 
volume of acidic stomach contents than their leaner counterparts thus increasing the 
potential for harmful reflux. However, a study by Harter et al showed that, in fact, the 
opposite holds true with obese patients having a lower volume of gastric contents 
and a higher pH (117). Similarly, gastric acid secretion has actually been found to be 
lower in morbidly obese patients (118). 
Despite  this,  there  is  good  evidence  that  oesophageal  acid  exposure  is 
increased in obese subjects. El-Serag et al and Cowell et al have both studied the 
effects of obesity on oesophageal acid exposure using conventional catheter-based 
24 hour pH monitoring and 48 hour wireless capsule pH-metry respectively. In the 
first study, El Serag et al found that both increased BMI and waist circumference 55 
 
were  associated  with  a  significant  increase  in  reflux  events,  long  reflux  events 
(>5mins),  time  pH<4  and  DeMeester  Score  (119).  Subsequently  Crowell  et  al 
confirmed  these  results  over  the  more  prolonged  monitoring  period,  showing  an 
increase in  total  acid  exposure  time  and  DeMeester  scores in  the  obese  subject 
group (120). 
It  has  traditionally  been  postulated  that  obesity  increases  the  mechanical 
stresses on the gastro-oesophageal junction. Increased abdominal girth could result 
in  increased  intra-abdominal  pressure  which  in  turn  could  promote  gastro-
oesophageal  reflux  by  increasing  intragastric  pressure.  Increased  intragastric 
pressure  potentially  increases  retrograde  flow  across  the  gastro-oesophageal 
junction  by  overcoming  the  lower  oesophageal  high  pressure  zone.  However,  as 
already described, the pathophysiology of GORD is multi-factorial and complex. As 
such, many possible mechanistic hypotheses exist to explain the role of obesity in 
reflux disease. 
Increased intragastric pressure has been described in obese subjects. This 
results in an increase in the gastro-oesophageal pressure gradient (GOPG) in line 
with  the  traditional  hypothesis  above  (121;122).  However,  in  obesity,  several 
morphological  changes  in  the  gastro-oesophageal  junction  have  also  been 
described. Since the GOJ provides the most important anti-reflux barrier, any change 
which  results  in  a  weakening  of  this  barrier  is  likely  to  be  important  in  the 
pathogenesis  of  reflux.  Lower  resting  LOS  pressure  and  shortening  of  the  LOS 
length  have  been  described  in  obesity  (123).  It  has  been  suggested  that  the 
increased  GOPG  that  exists  in  obesity  may  promote  the  development  of  hiatus 
hernia.  Certainly  several  studies  show  a  significant  positive  relationship  between 56 
 
obesity and the presence of a hiatus hernia, with an overall prevalence of 40% in 
obesity  versus  12.6%  in  the  general  population  (124).  The  association  of  hiatus 
hernia with GORD and oesophagitis is well described (33). Finally, Wu et al have 
previously demonstrated an association between obesity and post-prandial TLOSRs, 
the primary mechanism of reflux in patients with normal resting LOS pressure (125). 
Contradictory  evidence  exists  regarding  the  effect  of  weight  loss  on  reflux 
disease.  Studies  by  Fraser-Moodie  et  al  (126)  and  Jacobson  et  al  (112)  both 
demonstrated  a  reduction  in  reflux  symptoms  with  weight loss.  Kjellin  et  al (127) 
studied the effects of weight loss on clinical and physiological correlates of reflux. 
Conversely, they found no effect on symptoms of GORD, pH or manometry. If weight 
loss does not reduce GORD, this could be explained by the hypothesis that obesity, 
through a subsequent increase in the GOPG, provokes the development of a hiatus 
hernia. This may be due to axial pressure strain through the phreno-oesophageal 
ligaments and crural diaphragm. Once a hiatus hernia has developed, the alteration 
in  GOJ  morphology  and  associated  predisposition  to  reflux  may  be  permanent 
regardless of weight loss. 
 
4.6. Obesity and Barrett’s oesophagus 
Barrett’s oesophagus, the metaplastic change in oesophageal mucosa from 
its usual squamous epithelial lining to a specialized columnar epithelium, occurs due 
to  chronic  reflux  and  is  recognised  as  a  strong  risk  factor  for  oesophageal 
adenocarcinoma. A number of recent studies show an association between obesity 
and the risk of Barrett’s oesophagus. A retrospective cross-sectional study by Stein 57 
 
et al (128) looked at 65 cases of Barrett’s oesophagus compared with 385 controls. 
The risk of Barrett’s oesophagus was increased approximately 2.5 times in subjects 
who  were  overweight  or  obese.  While  these  results  may  be  expected  given  the 
association  between  obesity  and  increased  reflux,  a  study  by  Smith  et  al  (129) 
suggests that it may not simply be by promoting acid reflux that obesity influences 
the development of Barrett’s oesophagus. They performed a population-based case-
control study of 167 Barrett’s patients and 261 age and sex-matched controls, finding 
that obese subjects with reflux symptoms had a  markedly higher risk of Barrett’s 
oesophagus (OR 34.4) than subjects with reflux (9.3) or obesity (0.7) alone. 
 
4.7. Male sex, visceral obesity, Barrett’s oesophagus and adenocarcinoma of 
the oesophagus and GOJ 
It  is  recognised  that  Barrett’s  oesophagus  (130)  and  oesophageal 
adenocarcinoma (65) are significantly more common in males. A number of possible 
explanations for this gender difference exist. Barrett’s oesophagus and oesophageal 
adenocarcinoma both arise from a background of chronic inflammation and mucosal 
damage. Oestrogen, has been shown to suppress the inflammatory response and 
cytokine production (131;132). Similarly, females have lower iron stores during their 
reproductive  years  which  might  modify  the  degree  of  DNA  damage  arising  from 
chronic inflammation.  
Gender differences are also well recognized in the distribution and type of 
adipose  tissue.  For  any  given  body  mass  index  (BMI),  body  composition  differs 
between the sexes. Men have a higher lean mass while in women there is more 58 
 
adiposity (133). Furthermore, the distribution of fat in males tends to be more central 
but  predominantly  peripheral  in  females.  This  altered  fat  distribution  has  been 
demonstrated  using  magnetic  resonance  imaging  (MRI)  and  computerized 
tomography (CT) to correspond with greater visceral adipose tissue (VAT) and less 
subcutaneous  adipose  tissue  (SAT)  in  men  compared  with  women  (134;135). 
Similarly,  greater  VAT  is  found  in  caucasian  versus  non-caucasian  populations 
(136).  
A higher risk of Barrett’s oesophagus and oesophageal adenocarcinoma is 
seen in white males, in whom central (visceral) obesity predominates. Studies using 
CT  measurement  of  visceral  adiposity  support  the  association  between  central 
obesity and both Barrett’s oesophagus and oesophageal adenocarcinoma. 
Fat  distribution  may  act  through  a  mechanical  effect  promoting  the 
development  of  gastro-oesophageal  reflux  with  a  subsequent  increased  risk  of 
Barrett’s  oesophagus  and  oesophageal  adenocarcinoma.  Alternatively,  visceral 
adipose tissue is well recognised to be more  metabolically active and secretes a 
variety  of  biological  substances  which  may  be  pro-inflammatory  and  promote 
tumourigenesis (107). Potential mediators of carcinogenesis in obesity and biological 
pathways which have been implicated as contributory are listed in Table 4.2.  
A  number  of  possible  mechanisms  of  tumourigenesis  have  also  been 
described.  Altered  metabolism  and  increased  production  of  sex  hormones  and 
glucocorticoids occurs in obesity (137). The resulting increases in insulin resistance 
induce  compensatory  hyperinsulinaemia  with  increased  production  of  insulin-like 
growth factor 1. Increased cellular proliferation and impaired apoptosis may result, 
increasing  the  risk  of  metaplasia  and  neoplasia  (138).  Alternatively,  Leptin  may 59 
 
stimulate  tumour  cell  growth,  migration  and  invasion  as  well  as  enhancing 
angiogenesis (139). 
It  is  estimated  that  approximately  40%  of  patients  with  oesophageal 
adenocarcinoma  have  developed  the  disease  due  to  being  overweight  or  obese 
(140).  Several  large  prospective  epidemiological  studies  have  demonstrated  an 
increased risk of oesophageal adenocarcinoma and gastric cardia adenocarcinoma 
with increasing BMI (141-143). The strong positive relationship between obesity and 
these cancers persists when adjusted for meal size and physical activity (144) and 
obesity has also been found to be associated with the development of these cancers 
at an earlier age. Corley et al (145), using a nested case-control study design, have 
shown that increasing waist circumference is associated with an increased risk of 
oesophageal  adenocarcinoma,  independent  of  BMI.  This  data  again  supports  a 
strong association between the risk of oesophageal adenocarcinoma and visceral 
obesity. 
 
4.8. Obesity and the distal opening hypothesis 
As previously discussed, 30-50% of upper gastrointestinal cancers occur at 
the GOJ, often in otherwise asymptomatic patients. Distal opening of the LOS after 
meals could expose the distal oesophageal squamous mucosa to the harmful and 
potentially carcinogenic effects of acidic reflux.  
Previous  studies  in  respiratory  medicine  have  demonstrated  that  the 
diaphragm  moves  proximally  in  obesity,  particularly  when  lying  flat  (146-149). 
Therefore, the migration of the squamous oesophageal lining into the stomach may 60 
 
be more pronounced with increasing body mass index (BMI). This ‘distal opening’ 
may help to explain the increasing incidence of gastro-oesophageal junction cancers 
in western countries where there is also a trend to increasing BMI. 
 
4.9. Summary 
Western  countries  are  currently  experiencing  an  obesity  epidemic.  At  the 
same time, gastro-oesophageal reflux disease and its complications are becoming 
more common in these populations. Clear links exist between symptomatic GORD, 
Barrett’s oesophagus and oesophageal adenocarcinoma. Furthermore, obesity could 
theoretically exacerbate distal opening of the LOS with resultant acidification of the 
distal  oesophageal  squamous  mucosa  leading  to  acid-induced  inflammation, 
metaplasia and ultimately neoplasia. 
 61 
 
Table 4.1 WHO BMI Classification 
Classification  BMI (kg/m
2) 
Underweight  <18.5 
Normal  ≥18.5 and <25 
Overweight  ≥25 and <30 
Obese  ≥30 
 
Table 4.2. Potential mediators and pathways implicated the role of obesity in 
tumourigenesis 
Mediator  Pathways 
Adipokines  Complement Activation 
Cytokines  Renin Angiotensin System 
Tumour Necrosis Factor α (TNFα)  Altered Glucocorticoid Metabolism 
Insulin  Altered Sex Hormone Metabolism 
Plasminogen Activator Inhibitor 1   
Resistin   
Leptin   
Adiponectin   
Vascular Endothelial Growth Factor (VEGF)   62 
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5.1. Research Aims 
The aim of this series of experiments was to further investigate, in normal 
human  subjects,  the  basic  pathogenesis  of  gastro-oesophageal  reflux  and 
oesophageal columnar metaplasia.  
In particular: 
i.  to examine the effect of nitrite delivered in saliva, and the associated 
luminal  nitric  oxide  produced  on  reaction  with  acid  at  the  gastro-
oesophageal junction, on gastro-oesophageal function.  
ii.  to  investigate  anatomical  and  physiological  changes  at  the  GOJ 
following a meal 
iii.  to investigate the effect of age and obesity on the GOJ 
 
5.2. Methods 
 
5.2.1. Upper gastrointestinal endoscopy 
Prior to the first study day, the participant attended fasted for an endoscopy. 
This  was  carried  out  using  topical  anaesthesia  with  xylocaine  local  anaesthetic 
spray. The anatomy of the upper gastrointestinal tract was documented. Biopsies 
were  taken  from  both  gastric  antrum  and  body  for  rapid  urease  CLO  test  to 64 
 
document Helicobacter Pylori status. Endoscopy was carried out a minimum of one 
day before the first study day.  
 
5.2.2. pH studies 
All pH studies were performed using a specially designed antimony 12 sensor 
high-resolution  pH  catheter  (Synectics  Medical  Ltd,  Enfield,  UK)  as  previously 
described  (150).  The  catheter  was  2.1  mm  in  diameter,  flexible  and  had  12 
electrodes along its distal end with an external reference electrode for application to 
the upper arm – see Figure 5.1. The most distal pH electrode was located at the tip 
of the catheter and the other 11 electrodes were 30, 50, 61, 72, 83, 94, 105, 116, 
127,  138  and  172  mm  proximal  to  it  –  see  Figure  5.2.  Prior  to  nasal intubation, 
individual electrodes were calibrated in buffer pH 1.07 and 7.01. Data was collected 
and  analysed  using  PolygramNet®  software  (Medtronic  Inc.,  Fridley,  Minnesota, 
USA) and was exported and processed using our own custom-designed software for 
further detailed analysis. 
 
5.2.3. High-resolution manometry studies 
Manometry  was  performed  using  a  solid-state  high-resolution  manometry 
assembly (Manoscan®, Sierra Scientific Instruments Inc., Los Angeles, California, 
USA). The catheter comprises 36 circumferential pressure sensing elements spaced 
at 1cm intervals – see Figure 5.3. Each sensing element incorporates 12 radially 
dispersed pressure sensors able to detect pressure over a length of 2.5mm. Sector 
pressures are averaged to provide a circumferential pressure reading. The system 65 
 
was calibrated to 0 and 300mmHg using externally applied pressure prior to use. 
Furthermore  in  vivo  calibration  was  performed  at  body  temperature  (36-38°C). 
Immediately after extubation, while sensing-elements remained at body temperature 
and  were  exposed  to  atmospheric  pressure  a time  for  thermal  re-calibration  was 
selected. To correct for thermal drift, a change in measured pressure due to change 
in  temperature,  a  linear  correction  from  0mmHg  was  applied  to  the  exported 
manometry data. Robertson et al, from our own group, have previously characterized 
the  thermal  drift  which  occurs  in  prolonged  studies  using  the  Manoscan®  high-
resolution manometry (151). They have shown this to be a linear phenomenon and 
the above correction process significantly improves the accuracy of recordings using 
this system. 
Manometry  studies  were  analysed  using  specialized  analysis  software 
(Manoview®, Sierra Scientifics) – an example of a normal swallow viewed using the 
Manoview® analysis software is shown in Figure 5.4. In addition to this, manometric 
data  was  exported  and  processed  using  our  own  custom-designed  software  for 
further detailed analysis. 
 
5.2.4. Combined pH and manometry apparatus 
pH  and  manometry  apparatus  was  attached  using  adhesive  tape  with  pH 
sensor 7 adjacent to manometry sensor 29 – see Figures 5.5. and 5.6. This allowed 
accurate comparison of pH and manometry. The combined apparatus was passed 
per  nasally  and  attached  at  the  nose  using  adhesive  tape.  pH  and  manometry 
studies were synchronized electronically. 66 
 
5.2.5. Data processing 
Our pH and manometry studies were synchronized electronically by starting 
both recordings simultaneously. For all studies the raw manometry and pH data was 
extracted as text files from the Manoscan® and PolygramNet® software respectively. 
The 36 channel Manoscan® system records manometry data at a frequency of 40Hz 
while our high-resolution pH catheter records 8 readings per second for each of the 
12 sensors (8Hz). Therefore, for a study consisting of 15 minute fasting data and 90 
minute  post-prandial  data  this  generates  9,676,800  individual  data  points.  The 
synchronized  pH and  manometry  data  was  combined  using our  custom-designed 
‘ManpH’ software. This allowed us to compress the manometry data into 8 readings 
per second allowing direct comparison with the pH data. To do this the mean of the 
manometry recordings taken over each 0.125s was calculated from the raw data. 
This  reduced  to  2,419,200  the  number  of  individual  data  points.  It  also  allowed 
selection of specific time periods and provided text files that could be exported into 
Microsoft  Office  Excel  2007  (Microsoft®,  Redmond, Washington,  USA)  for  further 
analysis. 
 
5.2.6. Nitrite solutions 
Nitrite  solutions  were  pre-prepared  as  potassium  nitrite  by  the  Pharmacy 
Production Unit, Western Infirmary, Glasgow. Solutions were labelled A-D with the 
researcher blinded to the concentration of each solution until data analysis had been 
performed.  Stock  solutions  were  regularly  monitored  for  stability  of  nitrite 
concentrations, again the researcher was blinded to these results. 67 
 
The concentrations of potassium nitrite were 0, 0.286, 2 and 14mmol/l – 
details of the nitrite solutions are shown in Table 5.1. Each solution also contained 
1mmol/l Potassium Thiocyanate. Thiocyanate is normally present at this 
concentration in non-stimulated saliva but levels have been found to be lower in 
studies involving orogastric tube insertion and with increased salivary flow 
rates.(80;152) Solutions were prepared to a pH expected of normal saliva (pH 6.12 – 
6.38).  
Concentration of nitrite in saliva in the fasting state ranges between 50 and 
600µmol/l and rises several fold following ingestion of nitrate in the diet (79). The 
concentration of nitrite used in our highest dose was greater than that occurring in 
swallowed saliva after a nitrate–rich meal. It is equivalent to the total nitrite load in 
the study by Manning et al which demonstrated an increase in post-prandial TLOSRs 
following infusion of a NO-generating solution into the gastric cardia (93). 
In normal circumstances, the minimal total unstimulated salivary flow rate is 
defined as 0.1 ml per minute, and the minimal stimulated flow rate is 0.2 ml per 
minute. Maximal stimulated flow rate is 7 ml per minute. The 24-hour volume of 
salivary secretion has been estimated to be 500 to 1,500 ml, or an average flow of 1 
ml per minute. 
Table 5.2. shows the estimated potassium concentrations of saliva and gastric 
secretions  compared  with  our  solutions  over  the  90  minute  study  period.  The 
maximum safe nitrite dose for a healthy volunteer has been estimated by the World 
Health Organisation (WHO) as between 290 - 370 mg of nitrite (153). The maximum 
cumulative nitrite dose used in our study, over all 4 study days, was less than 20% of 
this value at 50.57mg. 68 
 
5.2.7. Controlling for variability in dietary nitrate intake 
To  control  for  variability in  dietary  nitrate intake  volunteers  were instructed 
regarding  measures  to  reduce  their  endogenous  salivary nitrite  content in  the  24 
hours prior to each study day. This included avoiding foods recognised as having a 
high nitrate concentration, such as salads and green leafy vegetables, as well as the 
twice  daily  use  of  0.2%  chlorhexidine  antibacterial  mouthwash.  Antibacterial 
mouthwash has been shown to reduce salivary nitrite concentrations by reducing 
bacterial reduction of salivary nitrate to nitrite.(154)  
 
5.2.8. Intra-oral nitrite delivery 
On each of the nitrite study days, the volunteers’ salivary nitrite concentrations 
were modified to a different level post-prandially by intra-oral infusion of potassium 
nitrite solutions. Following consumption of our standardised meal, a fine bore (1mm) 
catheter  (Vygon  (United  Kingdom)  Ltd,  Cirencester,  Gloucestershire,  United 
Kingdom) perforated at its distal end, was placed in the mouth for infusion of test 
solutions to modify salivary nitrite concentration – see Figure 5.7. Solutions were 
infused over 90 minutes at a rate of 0.5ml per minute. 
 
5.2.9. Quantification of salivary nitrite concentration 
Immediately  after  sampling,  1ml  of  saliva  was  mixed  with  50µl  of  1mmol/l 
NaOH. This rendered the sample alkaline, preventing nitrite being converted to nitric 
acid and lost. Samples were stored at 4ºC, then centrifuged on the same day at 
3000  rpm  for  10  minutes.  250µl  aliquots  were  subsequently  removed  from  the 
supernatant.  These  were  frozen  at  -20ºC  for  later  analysis.  Analysis  of  thawed 69 
 
samples  was  performed  on 96-well  microplates  using  a  modified  Griess  reaction. 
Colorimetric  analysis  was  performed  30  minutes  after  the  addition  of  the  Griess 
reagents using a 540nm filter. Analysis was performed at CBP laboratories, Western 
Infirmary and results blinded to researcher until after data analysis was complete. 
 
5.2.10. X-ray screening 
X-ray  screening  of  the  gastro-oesophageal  junction  was  carried  out  during 
normal  respiration  using  a  portable  C-arm  fluoroscope  (Philips  BV  Pulsera). 
Screening  was  performed  both  in  the  fasting  state  and  following  the  meal  for 
approximately 30 seconds and synchronized with pH manometry recordings using 
an  event  marker.  Images  were  recorded  using  a  digital  video recorder  (JVC SR-
DVM600E). Further analysis was performed using image analysis software (Scion 
Image,  Scion  Corporation,  Frederick,  Maryland,  USA).  The  position  of  the  clip 
relative  to  the  pH  and  manometry  catheters  was  calculated  with  the  measured 
distance of one pH sensor (known to be 1cm) used as an internal scale. An example 
of an X-ray screening still obtained during the study is shown in Figure 5.8. 
 
5.3. Statistical Analysis 
Statistical analysis was performed using MiniTab version 16 (Minitab, State 
College,  PA,  USA)  or  SPSS  version  18  (IBM,  New  York,  NY,  USA)  statistical 
software. 70 
 
Table 5.1 Details of nitrite solutions 
Nitrite Concentration 
(mmol/l) 
Total Nitrite Load (µmol)  Randomisation 
0  0  B 
0.26  12.87  C 
2  90  A 
14  630  D 
 
Table 5.2 Estimated electrolyte levels in stimulated saliva and post-prandial secretions 
and comparison with nitrite solutions 
Electrolyte 
Range in normal  
stimulated saliva 
(mg)* 
Range in post-
prandial gastric 
secretions (mg) † 
Maximum present in 
solutions infused 
(mg) 
Potassium  35.2 -105.6  71.0 – 699.6  26.56 
 
*Calculated from stimulated saliva flow rate of 1ml/min = 90ml over study period 
†Calculated from estimated 90-minute post-prandial gastric secretion volume of 506.9ml 
(155) 
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Figure 5.1. 12-sensor pH catheter 
 
 
 
Figure 5.2. pH catheter sensor spacing 
 
 
 
Figure 5.3. Manoscan® 36-sensor high-resolution manometer 72 
 
 
Figure 5.4. Manoview® analysis software – normal swallow 
 
 
 
Figure 5.5. Combined pH manometry apparatus 73 
 
 
Figure 5.6. Combined pH manometry apparatus alignment 
 
 
 
Figure 5.7. Intra-oral nitrite infusion catheter 
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Figure 5.8. Fluoroscopic screening image 75 
 
Chapter 6 
The Effect of Nitrite in Saliva on 
Gastro-oesophageal Reflux 76 
 
Chapter 6   
The Effect of Nitrite in Saliva on Gastro-oesophageal Reflux 
 
6.1. Introduction 
Human  saliva  has  a  high  nitrite  concentration  from  the  entero-salivary 
recirculation of dietary nitrate. Swallowed nitrite reacts with gastric acid to form nitric 
oxide  (NO)  at  the  gastro-oesophageal  junction.  This  may  contribute  to  the 
pathogenesis of reflux disease. NO has been shown to reduce lower oesophageal 
sphincter  (LOS)  pressure,  impair  oesophageal  clearance  and  may  be  the  final 
mediator  in  the  production  of  transient  lower  oesophageal  sphincter  relaxations 
(TLOSRs). 
 
6.2. Aims 
The aims of this study were: 
i.  to determine whether nitrite in swallowed saliva increases oesophageal 
acid exposure 
ii.  to establish whether nitrite in swallowed saliva modifies the manometric 
characteristics of the lower oesophageal sphincter 
iii.  to  examine  how  any  of  these  effects  relate  to  the  range  of  nitrite 
present  in human saliva.      
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6.3. Subjects 
Twenty-five non-smoking healthy subjects were recruited. In 2 subjects we 
were  unable  to  pass  the  pH  manometry  apparatus  per  nasally  while  a  further  3 
subjects  withdrew  due  to  discomfort  during the  procedure.  20  subjects  (11  male) 
completed the full study protocol with a mean age of 30.8 years (Range 19 – 59). 
The baseline characteristics of our study population are shown in Table 6.1. 
 
6.4. Methods 
   The subjects underwent studies of gastro-oesophageal function on 4 separate 
days with their saliva nitrite concentration modified to a different level on each of the 
days. The study day outline is illustrated in Figure 6.1. Two days prior to the first 
study  day,  upper  gastrointestinal  (GI)  endoscopy  was  performed  in  order  to 
document the anatomy of their upper GI tract.  Antral and body biopsies were taken 
for H. pylori rapid urease test. 
On  each  of  the  four  study  days,  subjects  reported  fasted  at  0900h  and  a 
combined  high  resolution  solid  state  manometer  probe  and  high  resolution  pH 
catheter were passed per nasally to allow detailed continuous recording of pressure 
and  pH  throughout  the  oesophagus,  gastro-oesophageal  junction  and  proximal 
stomach.  The high resolution manometer has 36 pressure sensors 1cm apart and 
records the pressure at each site 40 times per second as previously described (156). 
The custom-made pH catheter has 12 antimony sensors, with the nine electrodes in 
the region of the squamocolumnar junction 11 mm apart, and records the pH at each 
site  eight  times  per  second  as  previously  described  (150).    A  fine  bore  (1mm) 78 
 
catheter  was  placed  in  the  mouth  and  secured  to  the  teeth  for  infusion  of  test 
solutions into the mouth to modify salivary nitrite concentration.  The studies were 
performed with the patients sitting semi-upright. 
   After recording pH and manometry over a 15 min fasting period, the subjects 
consumed  a  standardized  meal  over  20  minutes  and  the  pH  and  manometer 
recordings continued for a further 90 minutes.  The meal consisted of two fishcakes 
and one rolled oats flapjack with 150ml water.  (Total calorie content = 526.35kcal).  
Infusions of the test solutions (0.5ml/min) into the mouth commenced immediately 
after  completion  of  the  meal  and  continued  throughout  the  90min  postprandial 
recording  period.    The  buccal  infusions  were  given  in  randomised  double  blind 
fashion containing 0, 0.286, 2 or 14 mmol/l potassium nitrite on the four separate 
study  days.    All  participants  were  instructed  regarding  measures  to  reduce  their 
endogenous  salivary  nitrite  content  over  the  48  hours  prior  to  each  test.      This 
consisted  of  avoiding  high  nitrate  containing  foods  and  twice  daily  use  of 
chlorhexidine  antibacterial  mouth  wash.    Samples  of  saliva  were  obtained  for 
determining the actual nitrite concentration during the fasting period and at 30 minute 
intervals following the commencement of the nitrite infusion on each study day.  The 
concentrations were not revealed until all the data were complete. 
Blood pressure and pulse rate were recorded on each study day prior to and 
following completion of the nitrite infusion. 
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6.5. Analysis  
6.5.1 Oesophageal acid exposure 
Acid exposure was calculated as %time pH<4 and recorded both at 5 - 6cm 
(traditional reflux) and 1 - 2cm (short-segment reflux) proximal to the fasting pH step-
up point.  Individual reflux episodes were identified using PolygramNet® software 
(Medtronic Inc., Fridley, Minnesota, USA). These were defined at 5-6cm according to 
the following criteria; i) pH fall to <4 with a minimum pH fall of 1 unit, ii) a minimum 
duration of event of 3 seconds and iii) a minimum interval of 10 seconds between 
events (157). The duration (in seconds) and nadir pH of each reflux event was also 
recorded.  
 
6.5.2. Manometry of the lower oesophageal sphincter 
Transient  Lower  oesophageal  Sphincter  Relaxations  (TLOSRs)  were 
identified  using  the  Manoview  analysis  software  and  defined  according  to  the 
Holloway criteria (20) which is detailed in Table 6.2. 
For more detailed analysis, the 15 minute period immediately before the meal 
and the 6 consecutive 15 minute periods after the meal were identified. During the 
last  10  minutes  of  each  period,  6  inspiratory  and  6  end-expiratory  points  were 
selected using a custom-made computer programme. The lower border of the LOS 
was defined as the most distal position where the pressure rose to > 2mmHg above 
gastric  baseline.  Similarly,  the  upper  border  of  the  LOS  was  defined  by  a  fall  in 
pressure to within 2mmHg of intragastric pressure. The expiratory and inspiratory 
pressures were defined as the highest recorded pressures within the LOS at each 80 
 
time-point. The respiratory inversion point (RIP) was defined as the point at which 
the  manometry  pressure  wave  decreases  on  inspiration.  Total  LOS  length,  intra-
thoracic  sphincter  length  and  intra-abdominal  sphincter  length  were  calculated  in 
expiration. 
To evaluate oesophageal peristalsis, using the Manoview® analysis software, 
a single completed swallow was identified from each of the 9 consecutive 10 minute 
periods following completion of the meal. The mean peristaltic wave velocity was 
calculated using measurements from 9cm and 5cm proximal to the mid-point of the 
lower  oesophageal  high  pressure  zone  (HPZ).  Mean  onset  velocity  (cm/s)  was 
calculated between 13cm and 5cm proximal to the mid-point of the high pressure 
zone. 
 
6.5.3. Intragastric pressure 
Intragastric  pressure  was  defined,  relative to  atmospheric  pressure,  as  the 
median pressure in the 3 sensors immediately distal to the LOS. 
 
6.6. Power calculations 
The primary outcome was oesophageal acid exposure.  Calculations indicated 
that recruiting 20 subjects would have power to detect a doubling (100% change) in 
values.  This assumes standard deviation of the percentage change in oesophageal 
acid exposure to be 105 and utilizes a significance level of 1% to account for the 81 
 
multiple comparisons that will be made with a two-sided test.  The standard deviation 
of the percentage change was derived from published data (158).  
 
6.7. Statistical analysis 
All results  are  given  as  medians  and interquartile  ranges unless  otherwise 
stated. The Wilcoxon signed-rank test was used to analyse the effect of the meal on 
the control day. To test the changes of variables against different nitrite solutions, the 
nonparametric  Friedman’s  test  or  Kruskal-Wallis  test  were  used.  The  Wilcoxon-
signed rank test or Mann-Whitney U test was used as post-hoc test in case of a 
significant (p value < 0.05) result of the Friedman’s or Kruskal-Wallis tests. 
 
6.8. Ethics 
The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant.  
 
6.9. Results 
Of  the  25  healthy  volunteers  recruited,  5  could  not  tolerate  the  nasal 
intubations and withdrew from the study.  Twenty (11 male, mean age 30.8 years, 
range 19-59; 18 H. pylori negative) completed the full study protocol.   
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6.9.1. Effect of the meal on gastro-oesophageal function on the control day 
We and others have reported previously that changes occur in the gastro-
oesophageal  junction  in  response  to  a  meal.    These  include  (i)  increased 
oesophageal acid exposure, (ii) increased frequency of TLOSRs, (iii) reduction in 
peak LOS pressure and (iv) reduction in overall LOS length due to loss of pressure 
in its most distal component (40;93). In order to confirm the validity of our recording 
equipment  and  experimental  set-up,  we  analysed  data  obtained  on  the  control 
infusion day to ensure that the expected changes were recorded in response to the 
meal.  Manometry  data  obtained  over  the  15  minute  initial  fasting  period  was 
compared with that over each six consecutive 15 min periods after commencement 
of the standardised meal. Results and p values are displayed in Table 6.3. 
 
6.9.1.a. Oesophageal acid exposure 
In the conventionally positioned sensor (5 - 6cm above fasting pH step-up 
point) the median percentage time oesophageal pH < 4 increased from 0% (0 - 1.89) 
during fasting to 0.49% (0 - 19.96) post-prandially (p=0.002). Similarly at the sensor 
located  1  -  2cm  above  the  fasting  pH  step-up  point,  acid  exposure  increased 
significantly after the meal from 1.21% (0 – 7.75) fasting to 6.01% (0.89 – 74.36) 
post-prandially (p<0.001). These results are illustrated in Figure 6.2. 
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6.9.1.b. Lower oesophageal sphincter  
There was an increase in the rate of TLOSRs following the meal from 0/hour 
(0 - 4) during fasting to 7.3 (4 - 11.3) post-prandially (p<0.001) – see Figure 6.3. 
Expiratory LOS pressure was reduced following the meal from 29.37mmHg (11.83 – 
51.19) to 19.18mHg (8.18 – 34.53; p=0.001) relative to atmospheric pressure and 
from  17.29mmHg  (4.9  –  37.76)  to  12.04mmHg  (4  –  23.79;  p<0.001)  relative  to 
intragastric pressure. Inspiratory LOS pressure was also reduced from 39.47mmHg 
(16.9  –  60.17)  to  30.42mmHg  (14.45  –  53.09;  p=0.02)  relative  to  atmospheric 
pressure and 25.35mmHg (10.11  – 43.9) to 18.13mmHg (6.50  – 40.25; p=0.035) 
relative to IGP. 
Although  the  absolute  reduction  in  LOS  pressure  following  the  meal  was 
similar  in  both  expiration  and  inspiration,  proportionally,  the  post-prandial  fall  in 
expiratory LOS pressure was greater than the reduction in inspiratory LOS pressure 
relative  to  both  atmospheric  pressure  and  IGP.  The  post-prandial  reductions  in 
expiratory  LOS  pressure  and  inspiratory  LOS  pressure,  relative  to  atmospheric 
pressure,  were  27.92%  (-9.15  –  71.76)  and  22.67%  (-139.86  –  59.3;  p=0.005) 
respectively.  Similarly,  when  taken  relative  to  intragastric  pressure,  the  end-
expiratory  reduction in  LOS  pressure  was  greater,  being  39.66%  (-30.74  –  78.8) 
versus a reduction in the inspiratory LOS pressure of 33.3% (-185.1-63.9; p=0.004). 
The result for each individual 15 minute post-prandial period is displayed in Figure 
6.4. 
Following the meal there was significant shortening of the LOS length, from 
5cm (3 – 6cm) to 4cm (1 – 6cm; p=0.001) during expiration, due to loss of the distal 
component of the LOS. While intrathoracic length was unchanged, median difference 84 
 
0cm (-1 – 2), intra-abdominal sphincter length was reduced, median difference 1cm 
(0 – 2; p<0.001) – see Figures 6.5 – 6.7. 
 
6.9.1.c. Intragastric pressure   
There was a trend towards a reduction in intragastric pressure following the 
meal.  Inspiratory  IGP  fell  from  11.99  (6.02  –  20.02)  fasting  to  10.25  (9.52  – 
21.79;p=0.059) after the meal. Expiratory IGP fell from 10.51mmHg (4.15 – 19.07) 
fasting to 8.93mmHg (3.22 – 20.4: p=0.089) after the meal. These results are shown 
in Figure 6.8.   
 
6.9.3. Effect of alteration in salivary nitrite on gastro-oesophageal function  
  The  analysis  of  salivary  nitrite  demonstrated  that  there  was  a  significant 
difference in the salivary nitrite concentrations on each of the four study days.  At 60 
minutes  following  the  meal  the  concentrations  of  salivary  nitrite  recorded  were 
24.3µmol/l (3.8 – 65.4), 80.4µmol/l (20.8 – 158.7), 372.8µmol/l (118.2 – 726.6) and 
2398.5µmol/l  (600  –  8087)  for  the  solutions  containing  0mmol/l,  0.286mmol/l, 
2mmol/l and 14mmol/l potassium nitrite respectively. The difference in salivary nitrite 
concentrations at 60 minutes is shown in Figure 6.9. 
 To  save  space  in  presenting  results,  the  four  different  study  days  will  be 
referred to as 1, 2, 3, 4 with one being the lowest nitrite concentration (control) and 4 
the highest. Results and p values are displayed in Table 6.4. 
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6.9.2.a Oesophageal acid exposure 
The percentage time pH<4 at 5-6cm above the fasting pH step-up point during 
the 90 min postprandial period was similar on each study day, being 0.43 (0 - 19.96), 
1.09 (0 - 35.8), 1.02 (0 - 28.09) and 0.57 (0 - 31.45) on days 1-4 respectively – see 
Figure 6.10.  At 1-2cm above fasting pH step-up point, the corresponding values 
were  also  not  different  from  each  other,  being  6.01  (0.84  –  74.36),  6.38  (0.81  – 
86.63), 9.67 (0.02 – 93.2) and 5.72 (0.08 – 68.64) – see Figure 6.11.  The number of 
reflux events was also similar on each study day being 2.5 (0 – 11), 5 (0 – 16), 4 (0 – 
17) and 2.5 (0 – 13) for study days 1-4 respectively– see Figure 6.12.  Duration of 
reflux events was also similar being 12.81 seconds (3.09 - 264.12), 14.98 seconds 
(3.24 – 301.15), 17.65 seconds (3.08 – 353.31) and 13.34 seconds (3.11 – 473.4) – 
see Figure 6.13. 
 
6.9.2.b. Lower oesophageal sphincter function 
  There was no difference in the number of TLOSRs recorded during the 90 
minute postprandial period between the different study days being 11 (6 - 17), 13 (6 - 
17), 12 (6 - 17) and 12 (7 - 18) for solutions 1-4 respectively – see Figure 6.14.   
Peak expiratory LOS pressure decreased following the meal on each study 
day relative to both atmospheric and intragastric pressure. Comparing the fasting 
and postprandial values for each individual showed that the change in LOS pressure 
following the meal was similar on each of the study days, being –8.03mmHg (-26.12 
– 2.08), -7.83mmHg (-37.56 – 7.72), -5.67mmHg (-42.37 – 12.82) and -8.33mmHg (-
55.57 – 4.13) relative to atmospheric pressure and  -7.14mmHg (-22.9 – 3.15), -86 
 
4.88mmHg (-37.04 – 5.75); -6.76mmHg (-42.08 – 14.7) and  -8.54mmHg (-51.83 – 
2.15) relative to IGP for solutions 1-4 respectively. 
The changes in the lower  oesophageal sphincter profile following the meal 
were similar on each study day including total length, intra-thoracic sphincter length 
and intra-abdominal sphincter length. 
 
6.9.2.c. Oesophageal peristalsis 
There was no difference in the peristaltic wave amplitude during the 90 min 
postprandial  period  on  the  four  study  days  being  36.5mmHg  (18.5  –  98.7), 
33.5mmHg (19.4 – 83.6), 33.4mmHg (21.1 – 79), 32.4mmHg (19.8 – 93.1) on days 
1-4 respectively – see Figure 6.15.  Peristaltic wave velocity was also similar on the 
four different study days being 5.2cm/s (2.6 – 11.3), 5.3cm/s (2.9 – 15.7), 4.8cm/s 
(2.8 – 26.5) and 4.8cm/s (3.1 – 17.9) on days 1-4 respectively – see Figure 6.16. 
 
6.9.2.d. Intragastric pressure 
Intragastric pressure fell following the meal on each study day.  Comparing 
the median fasting and median postprandial value for each individual showed that 
there was no difference in the change in intragastric pressure following the meal 
between the 4 study days when measured in either inspiration or expiration. The 
median  difference  being  -1.78mmHg  (-9.46  –  5.6),  -1.4mmHg,  (-6.1  –  3.5),  -
0.1mmHg, (-5.4 – 5.7) and -0.42mmHg, (-9.2 – 7.7; p>0.032) in inspiration and -87 
 
1.57mmHg (-7.2 – 4.81), -1.83mmHg (-5.21 – 2.05), -0.49mmHg (-5.45 – 4.54) and -
1.5mmHg (-9.19 – 6.15; p>0.112)) in expiration with solutions 1-4 respectively.   
 
6.9.3. Effect of alteration in salivary nitrite on blood pressure and pulse 
There was a significant difference in the change in systolic blood pressure 
(pre  to  post  infusion)  between  the  4  study  days  (p=  0.007,  by  Friedman’s  test). 
However,  on  post-hoc  analysis,  only  the  solution  containing  0.286mmol/l  nitrite 
showed a significant change in systolic blood pressure compared with the control 
solution. The change in systolic blood pressure was -4 mmHg (-29 – 18), 2.5 mmHg 
(-17 - 30; p<0.05 vs. control), -1 mmHg (-15 -24; p=0.85 vs. control) and -12 (-25 6; 
p= 0.17 vs. control) for solutions 1-4 respectively – see Figure 6.17. 
Diastolic  blood  pressure  and  pulse  rate  were  similar  following infusions  on 
each of the four study days – see Figures 6.18 and 6.19. 
 
6.10. Discussion 
The above studies demonstrate that the range of nitrite likely to be present in 
human saliva does not modify gastro-oesophageal function or predispose to gastro-
oesophageal reflux. 
 There are several reasons why we believe our findings are robust and that it 
is very unlikely that a clinically relevant effect has been missed.  Firstly, we studied 
the  effect  of  nitrite  over  a  100-fold  range  in  saliva  nitrite  concentrations  which 
extended from 50% of the normal lowest fasting concentrations to approximately ten 88 
 
times the peak concentrations reported following human nitrate ingestion.  Secondly, 
we confirmed with strong significance all the previously reported changes in gastro-
oesophageal  function  following  a  meal  indicating  that  our  study  protocol  was 
sensitive and robust (32,33). These changes included a fall in LOS pressure, loss of 
distal  component  of  LOS,  increase  in  frequency  of  TLOSRs  and  increased 
oesophageal acid exposure.  
On the control day we observed that the fall in LOS pressure following the 
meal  was  similar  during  inspiration  and  expiration  when  expressed  as  absolute 
values but greater during expiration when expressed as percentage fall.  The LES 
comprises two main components, the first being the intrinsic sphincter within the wall 
of the distal oesophagus and proximal stomach and the second being the extrinsic 
sphincter  formed  by  the  crura  of  the  diaphragm.    The  rise  in  LOS  pressure  on 
inspiration is due to the increase in pressure exerted by the diaphragmatic crura.  
The  intrinsic  sphincter  makes  a  greater  contribution  to  the  total  pressure  during 
expiration than inspiration.  The overall LOS pressure is thought to represent the 
sum of the crural pressure plus intrinsic sphincter pressure (34).  The fact that the fall 
in LOS pressure after the meal was proportionally greater during expiration suggests 
that it is due to a fall in the pressure exerted by the intrinsic sphincter.  This may be 
explained by the effects of cholecystokinin released after a fatty meal (159;160). 
We also observed a shortening of the length of the LOS following the meal 
during expiration mainly affecting the abdominal segment.  This is again consistent 
with relaxation of the intrinsic component. 
The ability to detect a change in the intrinsic component of the LOS in our 
study protocol was important as an effect of nitric oxide derived from the luminal 89 
 
nitrite would be on the intrinsic and not extrinsic sphincter.  Previous investigators 
have also demonstrated the ability to detect changes limited to the intrinsic sphincter 
while measuring overall LOS pressure. For example, atropine relaxes the intrinsic 
sphincter but does not affect the diaphragmatic crura and a fall in lower oesophageal 
sphincter pressure can be readily demonstrated following atropine during expiration 
(161). 
Could  an  effect  of  nitrite  be  limited  to  subjects  with  erosive  oesophagitis 
where  the  damage  to  the  epithelium  might  facilitate  the  nitric  oxide  reaching  the 
intrinsic muscle layer of the oesophagus.  It is probable that such subjects would be 
more  sensitive  to  the  presence  of  luminal  nitric  oxide  than  healthy  volunteers.  
However, in our study, the luminal nitrite concentration on one study day was 10 
times  higher  than  the  upper  range  of  normal  and  an  effect  would  have  been 
expected at this very high level even in subjects with an intact epithelium. 
  Webb et al have previously described a significant reduction in systolic blood 
pressure following dietary nitrate supplementation (162).  In our own study, the only 
significant  change  in  blood  pressure  or  pulse  was  an  increase  in  systolic  blood 
pressure following infusion of the solution containing 0.286mmol/l nitrite. However, 
with increasing dose of nitrite, there was a trend toward decreasing systolic blood 
pressure. In the study by Webb et al, depending on bacterial conversion of the re-
circulated nitrate, the amount of nitrite delivered may have been up to 9 times higher 
than the maximum nitrite load in our study. Also, unlike the study by Webb et al 
where  regular  blood  pressure  measurements  were  recorded  using  an  automated 
machine for up to 24 hours, BP and pulse were only recorded before initial nasal 
intubation  of  pH  manometry  apparatus  and  after  completion  of  the  infusion. 90 
 
Therefore, a transient effect of the administered nitrite during infusion could easily 
have been missed. Similarly a delayed effect on BP, as occurs in the study by Webb 
et al, would not have been detected. The possibility we may have missed a transient 
BP effect during the infusion of nitrite is supported by their observations that the in 
vivo half life of nitrite (~1.5 hours) was significantly longer than the ex vivo half life (< 
2 minutes), suggesting that nitrite was being continuously produced from nitrate (half 
life  of  ~  8  hours)  by  entero-salivary  recirculation.  Without  recirculation  of  dietary 
nitrate, in our own study the in vivo half life of the delivered nitrite is likely to be short. 
In  another  previous  study  by  our  own  group,  Manning  et  al  examined  the 
effect of infusing a nitrous acid solution and a nitric oxide generating infusion into 
gastric  cardia.  Results  were  compared  with  the  infusion  of  a  control  solution 
containing  hydrochloric  acid  (pH  1.0).  They  described  an  increase  in  the  rate  of 
TLOSRs  and  acid  exposure  with  the  NO-generating  solution  versus  control.  In 
addition,  there  was  an  attenuation  of  the  postprandial  increase  in  IGP  following 
infusion  of  the  nitrous  acid  infusion.  In  our  study  neither  of  these  changes  were 
demonstrated. However, differences in methodology between the two studies may 
be important. In the study by Manning et al infusions were delivered directly into the 
gastric cardia while, in our study, nitrite is continually infused into the oral cavity. In 
our study therefore, nitrite is not delivered to the GOJ until saliva is swallowed and 
therefore  delivery  of  nitrite  is  intermittent  which is  analogous  to  the  physiological 
delivery of nitrite in normal saliva. By continuously exposing the distal oesophagus, 
LOS and stomach to nitric oxide or nitrous acid without time to ‘recover’ Manning et 
al may have provoked an increase in TLOSRs which would not be induced by the 
physiological delivery of nitrite. In addition it is possible that following the infusion of 91 
 
the NO generating infusion into the gastric cardia, the increase in TLOSRs may have 
been triggered by distension of the proximal stomach. This may have occurred due 
to the production of NO gas which would have had a similar effect to the instillation 
of  air  into  the  proximal  stomach  which  is  recognised  as  a  potent  stimulator  of 
TLOSRs.  Any  increase  in  the  rate  TLOSRs  could  explain  the  increase  in  acid 
exposure recorded.  Finally as well as infusing nitrous acid and hydrochloric acid into 
the gastric cardia, Manning et al infused ascorbic acid as part of the NO-generating 
solution. As a result, the GOJ was exposed to super-physiological levels of ascorbic 
acid potentially leading to greater than physiological NO production. In our study no 
additional ascorbic acid was given, thus NO production is likely to be more in the 
physiological range and may therefore be reduced when compared with Manning et 
al. 
 
6.11 Conclusion 
Our  study  demonstrates  that  salivary  nitrite  and  its  associated  nitric  oxide 
production  on  reaction  with  acid  at  the  gastro-oesophageal  junction  does  not 
influence integrity of the gastro-oesophageal barrier in healthy volunteers. 92 
 
Table 6.1. Baseline characteristics of study group 
Parameter  Value 
Total Subjects Recruited  25 
Completed Study  20 (80%) 
Sex  Male 11 (55%)  Female 9 (45%) 
Helicobacter Status  Positive 3 (15%)  Negative 17 (85%) 
Age (y)  26.5 (range 19 – 59) 
Height (m)  1.72 (range 1.55 – 1.84) 
Weight (kg)  75.0 (range 55 – 110) 
BMI (kg/m
2)  23.7 (range 18.6 – 35.5) 
Waist Circumference (cm)  83.5 (range 67 – 110) 
Baseline Systolic BP (mmHg)  125 (range 114 – 161) 
Baseline Diastolic BP (mmHg)  75 (range 61 – 90) 
Baseline Pulse Rate (bpm)  70 (range 48 – 98) 
Values are medians (range) unless otherwise stated 93 
 
Table 6.2. Holloway criteria for definition of transient lower oesophageal sphincter 
relaxations (TLOSRs) (20) 
Criteria 
1.  Absence of swallowing for 4s before to 2s after r, the onset of LOS relaxation 
AND 
2.  Relaxation rate of ≥1mmHg/s 
AND 
3.  Time from onset to complete relaxation of ≤10 seconds 
AND 
4.  Nadir pressure ≤2mm 
OR 
5.  Any pressure falls fulfilling criteria 2-4 but with duration >10 seconds (excluding 
those associated with multiple swallows) 
 94 
 
Table 6.3. Changes in gastro-oesophageal function following the meal 
  Fasting  Post-prandial  p value 
5-6cm Acid Exposure 
(% time pH<4) 
0 (0–1.9)  0.5 (0-20)  p = 0.002 
1-2cm Acid Exposure 
(% time pH<4) 
1.2 (0-7.8)  6.0 (0.9-74.4)   p < 0.001 
Rate of TLOSRs 
(number/h) 
0 (0-4)  7.3 (4-11.3)  p = 0.001 
Expiratory LOS 
Pressure vATM 
(mmHg) 
29.4 (11.8-51.2)  19.2 (8.2-34.5)  p < 0.001 
Expiratory LOS 
Pressure vIGP 
(mmHg) 
17.3 (4.9-37.7)  12 (4-23.8)  p < 0.001 
Inspiratory LOS 
Pressure vATM 
(mmHg) 
39.5 (16.9-60.2)  30.4 (14.5-53.1)  p = 0.02 
Inspiratory LOS 
Pressure vIGP 
(mmHg) 
25.4 (10.1-43.9)  18.1 (6.5-40.3)  p = 0.035 
LOS Length (cm)  5 (3-6)  4 (1-6)  p = 0.001 
Inspiratory 
Intragastric Pressure 
(mmHg) 
12 (6-20)  10.2 (4.5-21.8)  p = 0.059 
Expiratory 
Intragastric Pressure 
(mmHg) 
10.5 (4.5-19.1)  8.9 (3.2-20.4)  p = 0.089 
TLOSRs, transient lower oesophageal sphincter relaxations; LOS, lower oesophageal 
sphincter; vATM, relative to atmospheric pressure; vIGP, relative to intragastric pressure.  
Results are expressed as medians (range). Significant p values (p <0.05) are highlighted in 
bold.95 
 
Table 6.4. Salivary nitrite concentrations and gastro-oesophageal and cardiovascular 
function on the four study days 
  0mmol/l  0.286mmol/l  2mmol/l  14mmol/l  p value 
Nitrite Concentration 
(mmol/l)* 
24.4 (3.9–65.5)  80.4 (20.9-158.8) 
358.4 (118.2-
726.6) 
2694 (600-8087)  p < 0.001† 
5-6cm Acid Exposure 
(% time pH<4) 
0.4 (0.0 – 20.0)  1.1 (0.0-35.8)  1.0 (0.0-28.1)  0.6 (0.0-31.5)  p = 0.214 
1-2cm Acid Exposure 
(% time pH<4) 
6.0 (0.8-74.4)  6.4 (0.8-86.6)  9.7 (0-93.2)  5.7 (0.1-68.6)  p = 0.981 
No. of TLOSRs  11.0 (6.0-17.0)  13.0 (6.0-17.0)  12.0 (6.0-17.0)  12.0 (7.0-18.0)  p = 0.117 
Change in Expiratory 
LOSP vATM (mmHg) 
– 8.0 (-26.1–2.1)  -7.8 (-37.6-7.7)  -5.7 (-42.4-12.8)  -8.3 (-55.6-4.1)  p = 0.776 
Change in Expiratory 
LOSP vIGP (mmHg) 
-7.1 (-22.9-3.2)  -4.9 (-37-5.8)  -6.8 (-42.1-14.7)  -8.5 (-51.8-2.2)  p = 0.73 
Change in Inspiratory 
IGP (mmHg) 
-1.8 (-9.5-5.6)  -1.4 (-6.1-3.5)  -0.1 (-5.4-5.7)  -0.4 (-9.2-7.7)  p = 0.13 
Change in Expiratory 
IGP (mmHg) 
-1.6 (-7.2-4.8)  -1.8 (-5.2-2.1)  -0.5 (-5.5-4.5)  -0.2 (-9.2-6.6)  p = 0.312 
No. of Reflux Events  2.5 (0.0-11.0)  5.0 (0.0-16.0)  4.0 (0.0-17.0)  2.5 (0.0-13.0)  p = 0.429 
Nadir pH of Reflux  1.6 (0.6-3.7)  1.5 (0.7-3.3)  1.6 (0.7-3.2)  1.6 (0.8-3.1)  p = 0.681 
Duration of Reflux 
(secs) 
12.8 (3.1-264.1)  15 (3.2-301.2)  17.7 (3.1-353.3)  13.3 (3.1-473.4)  p = 0.614 
Peristaltic Amplitude 
(mmHg) 
36.6 (18.5-98.7)  33.6 (19.4-83.6)  33.4 (21.1-79.0)  32.4 (19.8-93.1)  p = 0.936 
Peristaltic Velocity 
(cm/s) 
5.2 (2.6-11.3)  5.3 (2.9-15.7)  4.8 (2.8-26.5)  4.8 (3.1-17.9)  p = 0.093 
Change in SBP (mmHg)  -4.0 (-29.0-18.0)  2.5 (-17.0-30.0)  -1.0 (-38.0-29.0)  -12.0 (-25.0-6.0)  p = 0.007‡ 
Change in DBP (mmHg)  -1.0 (-18.0-11.0)  -4.0 (-27.0-17.0)  1.0 (-15.0-24.0)  -3.0 (-27.0-6.0)  p = 0.316 
Pulse (bpm)  -2.5 (-20.0-14.0)  -2.0 (-23.0-6.0)  -3.5 (-22.0-18.0)  1.5 (-22.0-6.0)  p = 0.903 
 
TLOSRs, transient lower oesophageal sphincter relaxations; LOSP, lower oesophageal sphincter pressure; 
vATM, relative to atmospheric pressure; vIGP, relative to intragastric pressure; SBP, systolic blood pressure; 
DBP, diastolic blood pressure. *Median nitrite concentrations at 60minutes post-prandial. Results are 
expressed as medians (range).  
Significant p values (p <0.05) are highlighted in bold. 
† Post-hoc test: (0.286 vs. 0), (2 vs. 0), and (14 vs. 0), p value for each was <0.001; ‡ Post-hoc test: (0.286 vs. 
0) p value <0.05, (2 vs. 0) p value = 0.850, and (14 vs. 0) p value = 0.170. 96 
 
 
Figure 6.1. The effect of nitrite in saliva on gastro-oesophageal reflux – study day outline 
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Figure 6.2. Box-plot showing the effect of the meal on oesophageal acid exposure 
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Figure 6.3. Box-plot showing the effect of the meal on the rate of transient lower 
oesophageal relaxations (TLOSRs) 98 
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Figure 6.4. Line graph illustrating the proportional fall in LOS pressure after the meal 
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Figure 6.5. Box-plot showing the change in lower oesophageal sphincter length after the 
meal 99 
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Figure 6.6. Box-plot showing the change in intra-thoracic sphincter length after the meal 
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Figure 6.7. Box-plot showing the change in intra-abdominal sphincter length after the 
meal 100 
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Figure 6.8. Line graph showing the change in intragastric pressure during study – control 
day 
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Figure 6.9. Box-plot of salivary nitrite concentrations between solutions - measured 60 
minutes into study 101 
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Figure 6.10. Box-plot of post-prandial acid exposure between solutions - measured 5-6cm 
above the fasting pH step-up point 
14mmol/l 2mmol/l 0.26mmol/l 0mmol/l
90
80
70
60
50
40
30
20
10
0
%
 
t
i
m
e
 
p
H
 
<
4
Acid Exposure (1-2cm)
 
Figure 6.11. Box-plot of post-prandial acid exposure between solutions - measured 1-2cm 
above the fasting pH step-up point 102 
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Figure 6.12. Box-plot showing the duration of individual post-prandial reflux events 
between solutions 
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Figure 6.13. Box-plot showing the nadir pH of individual post-prandial reflux events 
between solutions 103 
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Figure 6.14. Box-plot showing the number of post-prandial transient lower oesophageal 
sphincter relaxations (TLOSRs) between solutions 
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Figure 6.15. Box-plot showing the post-prandial peristaltic wave amplitude between 
solutions 104 
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Figure 6.15. Box-plot showing the post-prandial peristaltic wave velocity between 
solutions 
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Figure 6.17. Box-plot showing the change in systolic blood pressure between solutions 105 
 
14mmol/l 2mmol/l 0.26mmol/l 0mmol/l
30
20
10
0
-10
-20
-30
m
m
H
g
Change in Diastolic Blood Pressure
 
Figure 6.18. Box-plot showing the change in diastolic blood pressure between solutions 
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Figure 6.19. Box-plot showing the change in pulse rate between solutions106 
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Chapter 7  
The Effect of Nitrite in Saliva on Gastric Emptying 
 
7.1 Introduction 
Human saliva has a high nitrite concentration derived from the entero-salivary 
recirculation  of  dietary  nitrate.  Swallowed  nitrite  reacts  with  acidic  gastric  juice 
forming  nitrous  acid,  nitrosating  species  and  nitric  oxide  (NO).  Increasing  NO 
bioactivity, by inhibiting phosphodiesterase, enhances gastric accommodation and 
delays  gastric  emptying  (91).  Recently,  our  group  described  attenuation  of  the 
postprandial  rise  in  intragastric  pressure  (IGP)  following  intragastric  nitrous  acid 
infusion  (93).  We  now  wish  to  examine  the  effect  of  salivary  nitrite  on  gastric 
emptying. 
 
7.2. Aims 
The aims of this study were: 
i.  to investigate whether nitrite in saliva affects gastric emptying 
ii.  to determine whether nitrite in saliva alters postprandial IGP 
 
7.3. Subjects 
20 subjects (11 male) with a mean age of 30.8 years (Range 19 – 59) were 
studied. Helicobacter status was determined using rapid urease test with 17 testing 108 
 
negative and 3 positive for  Helicobacter pylori infection. All subjects were free of 
symptoms of gastro-oesophageal reflux and were not on any regular anti-secretory 
medications.  
 
7.4. Methods 
Gastric emptying studies following modification of salivary nitrite concentration 
were performed on 4 separate study days – the study day outline is shown in Figure 
7.1. Each patient acted as their own control. Volunteers attended for each study day 
fasted  from  the  night before.  To  measure  changes in intragastric  pressure,  high-
resolution manometry studies were also performed on each study day. 
 
7.4.1. High-resolution manometry 
High-resolution  manometry  was  performed  using  the  Manoscan®  system 
(Sierra Scientific Instruments Inc). At the beginning of each study, the manometry 
apparatus was passed per nasally and attached at the nose using adhesive tape. 
Volunteers  were  given  15  minutes  to  get  used  to  the  apparatus.  Manometry 
recording  was  then  performed  for  15  minutes  in  the  fasting  state  prior  to  the 
consumption of a standardised meal, and continued for 90 minutes post-prandially. 
 
7.4.2. Gastric emptying test 
Gastric emptying was assessed by means of a specially designed breath test 
which was based on the method described by Meier- Augenstein et al (163). This 109 
 
uses 
14C labelled sodium acetate incorporated into a flapjack consisting of butter, 
syrup  and  rolled  oats  during  the  baking  process.  The  flapjack  was  prepared  in 
batches and constituted part of our standardised meal.  
Following consumption of the flapjack, breath samples were taken at regular 
intervals to assess gastric emptying. Samples are taken at baseline then 10 minute 
intervals for 1 hour followed by 15 minute intervals for the subsequent 2 hours.
 14CO2 
breath  samples  were  collected  in  hyoscine  hydroxide  and  ethanol  scintillation 
medium. Each sample contains 1mmol of CO2 and is analyzed by beta scintillation 
counting. 
 
7.4.2.a. In vitro validation study of gastric emptying test 
Prior to the study, the radio-labelled flapjack was evaluated as an accurate 
and reproducible marker of the solid phase of a meal by assessing retention of the 
14C labelled sodium acetate in the solid phase under gastric simulation. 2g aliquots 
of the flapjack were added to 10mls of gastric juice (pH 1.44) obtained from a healthy 
volunteer and 1ml of fresh human saliva. Samples were immersed in a water bath at 
37ºC and mixed at regular intervals to simulate gastric motor activity. 4 individual 
samples were analysed at 30, 60, and 180 minutes. Samples were taken from the 
liquid phase to measure release of the tracer. The results were expressed as the 
mean percentage of the initial radioactivity that remained in the solid phase. 
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7.4.3. Standardised meal 
Each  volunteer  was  given  a  standardised meal,  consisting of  two  haddock 
and potato fishcakes and one rolled oats flapjack with 150ml of water (Total calorie 
content: 526.35 kcal). 20 minutes was allocated for consumption of the meal. 
 
7.4.4. Nitrite infusions 
Infusions of the test solutions into the mouth commenced immediately after 
completion of the meal and continued for 90 minutes post-prandially. 
 
7.5. Analysis 
7.5.1. Gastric emptying 
Total  CO2  production  was  taken to  be 300 millimoles  per  square  metre  of 
body surface per hour. Body surface area was calculated by the formula previously 
described by Haycock et al (164). The quantity of 
14C appearing in breath per unit 
time  (µmol/minute)  was  calculated.  The  mathematical  model  described  by 
Viramontes et al was used to estimate gastric half-emptying times (T½). This used 
only 4 breath samples at 45, 90, 105 and 120 minutes (165). In this method, the 
gastric emptying T½ is estimated directly as T½ = 1/LP½, where the linear predictor 
(LP½) is given by: 
LP½ = 0.0025 – 0.0039 x 
14C45 + 0.0088 x 
14C90 – 0.0063 x 
14C105 + 0.0024 x 
14C120 
 111 
 
7.5.2. Intragastric pressure 
Intragastric  pressure  was  defined,  relative to  atmospheric  pressure,  as  the 
median pressure in the 3 sensors immediately distal to the LOS. 
 
7.6. Statistical analysis 
All results  are  given  as  medians  and interquartile  ranges unless  otherwise 
stated.  To  test  the  changes  of  variables  against  different  nitrite  solutions,  the 
nonparametric Friedman’s test was used. 
 
7.7. Ethics 
The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant. 
 
7.8. Results 
7.8.1. In vitro validation study of gastric emptying test 
The bench top study confirmed the retention of the majority of tracer in the 
solid phase of the meal under gastric simulation. At 30, 60 and 180 minutes the 
mean percentage 
14C retention in the solid phase was 83.9% (range 73.7 – 89.6%), 
74.6% (range 65.3 – 79.2%) and 62.44% (range 52.1 – 66.4%) respectively - see 
Table 7.1. 112 
 
7.8.2 Salivary nitrite concentrations 
There was a significant difference in the median salivary nitrite concentrations 
during  infusion  of  each  solution.  At  60  minutes  following  the  meal  the  median 
concentrations of salivary nitrite recorded were 24.35µmol/l (range 3.86  – 65.46), 
80.42µmol/l (range 20.88 – 158.79; p<0.001 v control), 372.86µmol/l (range 118.2 – 
726.6; p<0.001 v control) and 2398.53µmol/l (range 600 – 8087; p< 0.001 v control) 
for the solutions containing 0mmol/l, 0.286mmol/l, 2mmol/l and 14mmol/l potassium 
nitrite respectively. The salivary nitrite concentration results are shown in Table 7.2. 
To  save  space  in  presenting  results,  the  four  different  study  days  will  be 
referred to as 1, 2, 3, 4 with one being the lowest nitrite concentration (control) and 4 
the highest. 
 
7.8.3. Gastric emptying – control v nitrite solutions 
There was no significant difference in the rate of gastric emptying of the test 
meal between the different study days with the  T½  being 39.79 minutes, (range 
10.94  –  136.69),  32.25  minutes,  (range  15.69  –  108.36);  33.98  minutes,  (range 
24.91 – 121.96) and 37 minutes, (range 19.7 – 363) for solutions 1 - 4 respectively. 
Results are shown in Figure 7.2. 
 
7.8.4. Intragastric pressure – control v nitrite solutions 
Intragastric pressure fell following the meal on each study day.  Comparing 
the median fasting and median postprandial value for each individual showed that 113 
 
there was no difference in the change in intragastric pressure following the meal 
between the 4 study days when measured in either inspiration or expiration. Results 
are shown in Figures 7.3. and 7.4. 
 
7.9. Discussion 
Our  initial  in  vitro  results  support  the  previous  observation  by  Meier- 
Augenstein  et  al  that  the  sodium  acetate-labelled  ‘radioactive  flapjack  test’  is  a 
reliable measure of solid-phase gastric emptying (163). The sodium acetate breath 
test had previously been described as an accurate, reliable and non-invasive tool for 
the analysis of liquid phase gastric emptying rates (166). Meier-Augenstein’s work 
subsequently demonstrated retention of a majority of the tracer in the solid phase of 
the meal if incorporated in the baking process of a rolled-oats flapjack. Similar results 
were found in our own study with a majority of the tracer retained in the solid phase 
under simulated intragastric conditions out to 180 minutes. Confirmation of tracer 
retention in the solid phase was important as measurement of solid gastric emptying 
is recognised to be more sensitive than measurements of liquid gastric emptying in 
detecting individuals with delayed gastric emptying (167)  
We calculated the gastric half-emptying time (T½) as a measure of the rate of 
gastric emptying.  Initially we used the mathematical model previously described by 
Ghoos et al (168;168), by fitting the percentage
14C recovery per minute by non-linear 
regression to the formula y = a
bte
-ct and the cumulative recovery of 
14C to the formula 
y = m(1-e
-kt)
β, the inverse of the scintigraphic decay curve. Through mathematical 114 
 
curve fitting, it is then possible to calculate the gastric half-emptying time (T½) using 
the equation (-1/k)ln(1-2
-1/β). 
However,  using  the  Ghoos  method,  we  frequently  observed  an  atypical 
double-peak in our excretion curves. This has previously been described by Sanaka 
et al and inevitably results in poor curve-fitting. Such a phenomenon was seen in at 
least one gastric emptying study in 14/20 subjects (70%). One possible cause for the 
frequency of this ‘double-peak’ phenomenon in our own study may have been that 
the nitrite infusion and manometry studies were only continued for 90 minutes, not 
the full 180 minutes over which breath testing was performed. Even in the absence 
of  a  direct  effect  of  salivary  nitrite  on  gastric  emptying  these  changes,  including 
removal of the nasogastric manometry catheter may have an impact upon gastric 
emptying.  As  a  result  of  this  finding,  the  mathematical  model  described  by 
Viramontes  et  al,  and  detailed  in  the  methods  section  above,  was  preferred  for 
estimation of gastric half-emptying times (T½). 
Despite  an  excellent  range  of  modified  salivary  nitrite  concentrations 
extending  over  and  beyond  the  normal  physiological  range,  we  were  unable  to 
demonstrate  any  effect  of  salivary  nitrite  modification  on  gastric  emptying  or 
postprandial changes in IGP. 
In previous work by Manning et al from our own group, the effect of infusing a 
nitrous acid solution and a nitric oxide generating infusion into gastric cardia was 
studied. The researchers found that there was an attenuation of the postprandial 
increase  in  IGP  following  infusion  of  the  nitrous  acid  infusion.  It  was  therefore 
postulated that this may have been due to a delay in gastric emptying. In our study 
neither  an  attenuation  in  IGP  nor  a  delay  in  gastric  emptying  was  observed. 115 
 
However, as detailed in the previous chapter, differences in methodology between 
the two studies may be important. In particular the mode of delivery of infusions and 
the excess ascorbic acid delivered to the GOJ and stomach may produce results 
which  would  not  be  seen  with  the  more  physiological  delivery  of  nitrite  we  have 
employed. 
While  our  in  vitro  gastric  simulation  confirms  that  the  majority  of  tracer  is 
retained in the solid phase of the meal throughout our study, the actual amount of 
tracer retained in the solid phase is lower than either Meier-Augenstein (74.6% v 
95.2% at 1 hour) or Ghoos (62.4% v 86.8% at 3 hours) have described (163;168). 
Similarly,  the  median  gastric  half-emptying  times  we  obtained  are  significantly 
shorter than those obtained by Ghoos et al in their study using a 
14C-octanoic acid 
solid emptying breath test meal correlated with radioscintigraphy. Indeed our results 
more  closely  resemble  their  median  values  for  the  lag  phase  of  solid  gastric 
emptying. No lag phase is present in liquid emptying and the lower in vitro retention 
and shorter emptying times may suggest that we have in fact measured liquid rather 
than  solid  gastric  emptying.  Although  solid  emptying  may  be  more  sensitive  in 
detecting delayed gastric emptying,  the  majority  of  patients  with  gastric  emptying 
disorders have delayed emptying of both liquids and solid food. The use of subjects 
as  their  own  control  makes  it  unlikely  any  significant  effect  of  salivary  nitrite  on 
gastric emptying would have been missed.  
It is also possible that liquid gastric emptying is more relevant to GORD than 
solid emptying. The rate of liquid emptying is largely determined by the degree of 
fundic relaxation (accommodation) while the emptying of solids depends more on 
antral motility (169). Abnormalities in gastric accommodation are more likely to lead 116 
 
to  increased  pressure  in  the  proximal  stomach  and,  through  the  generation  of 
TLOSRs,  to  increased  gastro-oesophageal  reflux.  Importantly,  in  the  study  by 
Sarnelli et al where they examined the impact of increasing NO bioavailability  by 
using the phosphodiesterase inhibitor Sildenafil, they demonstrated an increased in 
gastric accommodation and a delay in liquid rather than solid gastric emptying (91). 
 
7.10 Conclusion 
Despite an excellent range of salivary nitrite concentrations, extending over 
and  beyond  the  normal  physiological  range,  no  difference  in  the  rate  of  gastric 
emptying or postprandial rise in IGP was seen. This suggests salivary nitrite does 
not affect gastric emptying. 117 
 
Table 7.1. In vitro study of tracer retention in the solid phase 
Time (Minutes) 
14C Retention (%) 
30  83.9 (73.7 – 89.6) 
60  74.56 (65.3 – 79.2) 
180  62.44 (52.1 – 66.4) 
Values are medians (range) 
 
Table 7.2. Salivary nitrite concentrations (mmol/l) at baseline and during 90 minute post-
prandial infusion 
Time 
0mmol/l 
Solution 
0.286mmol/l 
Solution 
2mmol/l 
Solution 
14mmol/l 
Solution 
0 minutes  18.77  22.73  19.01  25.25 
30 minutes  28.61  60.95  349.68  2776.28 
60 minutes  24.35  80.42  358.44  2693.83 
90 minutes  26.49  32.84  138.56  886.45 
Results shown are median values. 118 
 
 
Figure 7.1. The effect of nitrite in saliva on gastric emptying – study day outline 
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Figure 7.2. Box-plot showing gastric half-emptying time between solutions 
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Figure 7.3. Box-plot showing the change in intragastric pressure (inspiratory) between 
solutions 120 
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Figure 7.4. Box-plot showing the change in intragastric pressure (expiratory) between 
solutions 121 
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Chapter 8 
Detailed  Analysis  of  Post-prandial  Changes  in  Gastro-oesophageal 
Morphology and the Effect of Salivary Nitrite 
 
8.1. Introduction 
30-50% of upper gastrointestinal tract adenocarcinomas occur at the gastro-
oesophageal junction (GOJ) or gastric cardia. Unlike oesophageal adenocarcinoma, 
the association with reflux is weak. In studies using pull through pH and manometry, 
we have observed loss of the distal segment of the lower oesophageal sphincter 
(LOS)  with  the  pH  step-up  point  moving  closer  to  or  even  across  the 
squamocolumnar junction (SCJ). This distal opening may explain the high incidence 
of pathology at the GOJ in asymptomatic subjects. 
 
8.2. Aims 
The aims of this study were to investigate, in healthy subjects using static high 
resolution manometry 
i.  the effect of a meal on manometric changes in the gastro-oesophageal 
high pressure zone (HPZ), the location of the pH step-up point and the 
position of the SCJ   
ii.  whether nitrite in saliva influences the effect of a meal on manometric 
changes  in  the  gastro-oesophageal  high  pressure  zone  (HPZ),  the 
location of the pH step-up point and the position of the SCJ 123 
 
8.3. Subjects 
20 healthy subjects (11 males, 17 Helicobacter Pylori negative) were studied 
over 4 separate study days. 
 
8.4 Methods 
8.4.1.  Endoscopic  placement  of  radio-opaque  clip  at  the  squamocolumnar 
junction (SCJ) 
A minimum of 24 hours prior to the first study day, subjects attended for upper 
gastrointestinal  endoscopy.  At  endoscopy,  a  radio-opaque  11mm  stainless  steel 
endoclip (Olympus HX-600-090) was placed at the macroscopic squamo-columnar 
junction using an endoscopic clip-fixing device (Olympus HX-5LR-1). Placement of 
this clip allowed subsequent fluoroscopic localisation of the SCJ. 
 
8.4.2. pH manometry 
On each study day, combined high-resolution pH manometry apparatus was 
passed per nasally as previously described. The apparatus was secured at the nose 
using  adhesive  tape  and  15  minutes  allowed  for  subject  accommodation  to  the 
apparatus.  Following  this,  synchronized  recording  of  pH  and  manometry  was 
performed for 15 minutes fasting, during our standardized meal and for 90 minutes 
post-prandially. 
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8.4.3. Standardized meal 
Our standardized meal consisted of two fishcakes and one rolled oats flapjack 
with 150ml water.  (Total caloric content = 526.35kcal).   
 
8.4.4. Nitrite infusions 
Infusions of the test solutions into the mouth commenced immediately after 
completion of the meal and continued for 90 minutes post-prandially. 
 
8.4.5. X-ray localization of the SCJ 
X-ray  screening  of  the  gastro-oesophageal  junction  was  carried  out  during 
normal  respiration  using  a  portable  C-arm  fluoroscope  (Philips  BV  Pulsera). 
Screening  was  performed  both  in  the  fasting  state  and  following  the  meal  for 
approximately 30 seconds and synchronized with pH manometry recordings using a 
radio-opaque event  marker.  Images  were  recorded  using  a  digital  video recorder 
(JVC SR-DVM600E). 
 
8.5. Analysis 
8.5.1. Detailed Analysis of the Gastro-oesophageal Junction 
To  examine  the  gastro-oesophageal  junction  in  more  detail,  10  second 
periods of stable sphincter tone out with sphincter relaxations were identified using 
the Manoview Analysis software during fasting and for each of the 6 consecutive 15 125 
 
minute periods following completion of the meal. The raw data was extracted and 
analysed  to  determine  the  mean  positions  of  the  distal  border  of  the  lower 
oesophageal  high  pressure  zone  (DHPZ),  the  proximal  border  of  the  lower 
oesophageal high pressure zone (PHPZ), the respiratory inversion point (RIP) and 
the pH step-up point. The DHPZ was defined as the most distal point where there 
was an increase of >2mmHg in pressure above the sensor recording gastric baseline 
pressure  (defined  as  the  lowest  mean  pressure  in  the  most  distal  6  manometry 
sensors). The PHPZ was identified as the point where there was a step-down in 
pressure to intra-oesophageal pressure. The RIP was defined as the point at which 
the manometry pressure wave decreases on inspiration. The pH step-up point was 
identified as the point where the mean pH increased to >4. The mean length of the 
high pressure zone (HPZ), the intra-abdominal component of the HPZ and the intra-
oesophageal component of the HPZ were calculated. 
To correct for errors in measuring the position of the PHPZ, DHPZ and RIP 
using 1cm increments, 0.5cm was added to the distance from the nares for each 
measurement. Similarly to correct for errors in measurement of the pH step-up point 
using 1.1cm increments, 0.55cm was added to the mean position of the pH step-up 
point. 
 
8.5.2. Measurement of SCJ position 
10  second  periods  of  stable  sphincter  tone,  out  with  sphincter  relaxations, 
were  identified  during  screening  episodes  using  the  Manoview  analysis  software. 
Corresponding still X-ray images at 2 second intervals were analysed using image 126 
 
analysis software (Scion Image, Scion Corporation, Frederick, Maryland, USA). The 
position of the clip relative to the pH and manometry catheters was calculated with 
the measured distance of one pH sensor (known to be 1cm) used as an internal 
scale. The mean SCJ position for the 10 second period was calculated. 
 
8.6. Statistical Analysis 
Statistical  analysis  was  performed  using  the  one-sample  Wilcoxon  test  or 
Mann Whitney U unless specified otherwise. The Bonferroni method was used to 
correct  for  the  use  of  multiple  comparisons  with  value  of  p<0.0083  considered 
significant.  
 
8.7. Ethics 
The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant 
 
8.8. Results 
8.8.1. Salivary Nitrite Concentrations 
There was a significant difference in the median salivary nitrite concentrations 
during infusion of each solution. 
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8.8.2. Changes after the meal – control solution 
8.8.2.a. Detailed analysis of the gastro-oesophageal junction 
Following the meal the PHPZ was unchanged from its fasting state but there 
was significant shortening of the HPZ, a maximum of 2.08cm (-0.48 – 5.59; p<0.001) 
see Figure 8.1. There was, therefore, significant proximal movement of the DHPZ 
relative to the nares, a maximum of 2.14cm (-1.37 – 4.23; p<0.001). In addition there 
was proximal movement of the RIP relative to the PHPZ, a maximum 1.09cm (0 - 
1.43;  p<0.001),  as  a  result  there  was  shortening  of  both  the  intra-oesophageal 
(maximum  1.11cm,  range  -0.55  –  4.36;  p<0.001)  and  intra-abdominal  (maximum 
1.15cm, range -1.43 – 3.53; p=0.007) components of the HPZ. The pH step-up point 
also moved proximally, a maximum of 1.61cm (-1.49 – 5.15; p<0.001). The changes 
occurring at the GOJ following the meal are illustrated in Figure 8.2. 
 
8.8.2.b. SCJ position 
18 subjects underwent X-ray screening on the day of the control infusion. In 
the remaining 2 subjects, videofluoroscopy equipment was unavailable at the time of 
study. In 5 of the subjects screened the endoclip had spontaneously dislodged and 
they  were  excluded  from  further  analysis.  SCJ  position  was  calculated  in  the 
remaining 13 subjects. Following the meal the DHPZ moved significantly closer to 
the SCJ, a median 1.72cm (-0.37-2.93, p=0.004). However, there was no difference 
in the position of the pH step-up point relative to the SCJ between the fasting and 
postprandial screening episodes with the median position being 0.62cm distal to SCJ 
(-2.25–5.93, p>0.4). These results are illustrated in Figure 8.3. 128 
 
An illustration of the changes at the GOJ following the meal is shown in Figure 8.4. 
8.8.3. Effect of Salivary Nitrite on GOJ Morphology 
8.8.3.a. Detailed Analysis of the Gastro-oesophageal Junction 
The  position  of  the  PHPZ  following  the  meal  was  similar  between  all  the 
solutions (p>0.08). There was no difference in the position of the RIP following the 
meal between the control solution and the nitrite-containing solutions (p>0.05). With 
all  solutions,  the  median  length  of  the  HPZ  and  the  length  of  both  the  intra-
oesophageal HPZ and the intra-abdominal HPZ was reduced following the meal with 
no  significant  difference  in  lengths  between  the  control  solution  and  the  nitrite-
containing solutions (p>0.05, p>0.01 and p>0.13) respectively. Finally, the median 
distance of the pH step-up point relative to the PHPZ was reduced following the meal 
with all solutions, again there was no difference in the position of the pH step-up 
point  relative  to  the  PHPZ  between  the  control  solution  or  the  nitrite-containing 
solutions (p>0.04). These results are shown in Figures 8.5. – 8.7. 
 
8.8.3.b. SCJ position 
Due  to  lack  of  availability  of  equipment  or  spontaneous  clip  dislodgement, 
only  7  subjects  had  suitable  X-ray  screening  images  available  for  comparison 
between all solutions. There was no significant change in the position of the pH step 
up point relative to the SCJ following the meal between the control solution (0.69cm, 
-0.26-2.97)  and  those  containing  0.286mmol/l  (-0.69cm,  -5.15  –  0.15;  p>0.03  v 
control), 2mmol/l (-0.24cm, -2.08 – 2.86; p>0.1 v control) and 14mmol/l potassium 
nitrite (-1.07cm, -2.39 - 4.9; p>0.15 v control). With all solutions, following the meal 129 
 
the DHPZ moved closer to the SCJ but there was no difference between the control 
solution (-0.26cm, -2.7 - 0.37) and those containing 0.286mmol/l (-0.8cm, -3.21 – 
0.5;  p>0.93  v  control),  2mmol/l  (-0.89cm,  -3.42  –  0.51;  p>0.35  v  control)  and 
14mmol/l  potassium  nitrite  (-0.38cm,  -3.64  –  1.15;  p>0.67  v  control)  when  the 
change in DHPZ position relative to the SCJ was compared. 
 
8.9. Discussion 
This study combines, for the first time, high resolution pH manometry with X-
ray localization of the SCJ to provide detailed analysis of the GOJ during fasting and 
in  the  post-prandial  state.  By  analysing  the  GOJ  in  more  detail,  we  have 
demonstrated that following the meal there is no difference in the position of the 
PHPZ but significant proximal movement of the DHPZ. As a result there is significant 
shortening  of  the  HPZ.  Proximal  movement  of  the  RIP  occurs  which  would  be 
consistent  with  cephalic displacement  of  the  diaphragm  by  a  distended  stomach. 
With X-ray screening the DHPZ is seen to move significantly closer to the SCJ after 
the  meal  and  the  pH  step  up  point  migrates  proximally.  These  changes  are 
consistent with distal opening of the LOS. This mechanism was first proposed by 
Oberg  and  DeMeester  (94;106)  and  has  recently  been  demonstrated  using  pull-
through manometry (93;170). It has been proposed as a mechanism by which distal 
oesophageal  exposure  may  occur  (intra-sphincteric  reflux)  and  as  a  possible 
explanation  for the recently described  paradox  of  postprandial  acidification  of the 
gastric cardia (171). This is the first study using static high-resolution manometry 
which confirms distal opening of the LOS after meals. The fact that we were unable 
to demonstrate any change in the position of the pH step-up point relative to the SCJ 130 
 
after  the  meal,  consistent    with  intra-sphincteric  reflux,  is  likely  to  be  due  to  the 
methods used in our study and the subjects examined. Studies were performed with 
subjects semi-recumbent at 45º to the horizontal, while the screening group also had 
a  median  body  mass  index  (BMI)  in  the  normal,  healthy  range  of  23.92.  Intra-
sphincteric  reflux  is  presumably  more  likely  to  occur  in  obese  subjects  in  whom 
cephalic displacement of the diaphragm and raised intragastric pressures are well 
documented (121;146-148). Similarly posture is likely to be important with cephalic 
displacement of the diaphragm being well documented to occur on lying flat. (149). 
 
8.10. Conclusion 
    This study confirms, using high-resolution pH manometry, that distal opening 
of the LOS and proximal migration of the pH step-up point occurs after a meal. The 
results  suggest  that  this  may  in  part  be  mediated  by  proximal  movement  of  the 
diaphragm. This mechanism may be important in the pathogenesis of disease at the 
GOJ. However, no effect on post-prandial gastro-oesophageal morphology was seen 
with modification of salivary nitrite concentrations.  131 
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Figure 8.1. Line graph showing significant shortening of the LOS postprandially 
*maximum 2.08cm (range -0.48-5.59cm) at 60-75 mins (p<0.001) 
 
 
 
 
 
Figure 8.2. Line graph showing changes occurring at the GOJ following the meal 
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Figure 8.3. Line graph showing the change in the position of the SCJ and pH step-up point 
post-prandially 
 
Figure 8.4. Illustration of changes occurring at the GOJ following a meal. Results are 
median values at 90 minutes post-prandially. (Note: the median pH step-up point was 
0.2cm proximal to the median SCJ position but this did not reach statistical significance) 133 
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Figure 8.5. Line graph showing shortening of HPZ following the meal 
90mins 75mins 60mins 45mins 30mins 15mins Fasting
6
5
4
3
2
Time in Study
D
i
s
t
a
n
c
e
 
(
c
m
)
0 mmol/l
0.26 mmol/l
2 mmol/l
14 mmol/l
Solution
Position of pH step-up Point Relative to PHPZ
 
Figure 8.6. Line graph showing pH step-up point moves proximally after the meal 134 
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Figure 8.7. Box-plot showing the post-prandial position of the pH step-up point relative 
to the SCJ135 
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Chapter 9 
Increasing Age and Obesity is Associated with Proximal Migration of the SCJ 
in Healthy Volunteers 
 
9.1. Introduction 
The gastric cardia is an important site of pathology with a high incidence of 
inflammation,  metaplasia  and  neoplasia.  However  this  complex  area  is  poorly 
understood and it has been proposed that cardia mucosa itself may be pathological, 
arising  from  columnar  metaplasia  of  the  distal  oesophageal  squamous  mucosa. 
Previous autopsy studies show a near absence of cardia epithelium in neonates and 
an increase in length with age (98;99). 
 
9.2. Aims 
The aims of this study were: 
i.  to  determine  if  the  position  of  the  squamocolumnar  junction  (SCJ) 
within the gastro-oesophageal high pressure zone changes with age in 
healthy subjects  
ii.  to examine the influence of waist circumference (WC) and body mass 
index  (BMI)  on  squamocolumnar  position  within  the  gastro-
oesophageal high pressure zone. 
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9.3 Subjects 
15  Helicobacter  pylori  negative  subjects  (9  males)  who  were  free  of  any 
gastrointestinal symptoms were studied. 
 
9.4. Methods 
Each subject underwent upper GI endoscopy with clipping of a radio-opaque 
endoclip at the squamocolumnar junction. On a separate study day, synchronized 36 
sensor  high  resolution  manometry  and  videofluoroscopy  was  performed  with 
subjects fasted and in a semi-recumbent position. Age, WC (cm) and BMI (m/kg
2) 
were recorded for each individual 
 
9.5. Analysis 
A  10  second  analysis  period  of  stable  sphincter  tone  (excluding  sphincter 
relaxations) was selected. The proximal high pressure zone (PHPZ) was identified 
from manometry data as a step-down in pressure to the intrathoracic pressure. The 
location of the SCJ was determined using image analysis software (Scion Image, 
Scion Corporation, Frederick, Maryland, USA) with the measured distance of a pH 
sensor (known to be 1cm) used as a scale. The distance between the position of the 
SCJ and the proximal HPZ was calculated for each individual. 
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9.6. Statistical Analysis 
  Spearman’s  rank  correlation  coefficient  was  used  for  analysis  of  non-
parametric data. Results are medians and ranges unless otherwise stated. 
 
9.7. Ethics 
  The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant. 
 
9.8. Results 
  The median age of the subjects was 25 years (20-59 years). The median BMI 
was 22.7 kg/m
2 (18.6 - 34.7 kgm
2) while the median waist circumference was 82cm 
(66 - 110cm). The median distance between the SCJ and PHPZ was 3.59cm (0.31 - 
4.46cm). The baseline characteristics of our study population are shown in Table 
9.1. 
 
9.8.1. Effect of age on SCJ position 
  There was a strong negative correlation between age and distance between 
SCJ  and  PHPZ  (R  =  -0.624;  p  =  0.013)  –  results  shown  in  Figure  9.1.  This 
correlation was even stronger when the male sub-group was analysed (R = -0.814; p 
= 0.008) – results shown in Figure 9.2. 
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9.8.2. Effect of BMI on SCJ position 
  There was a strong negative correlation between age and distance between 
SCJ  and  PHPZ  (R  =  -0.596;  p  =  0.019)  –  results  shown  in  Figure  9.3.  This 
correlation was even stronger when the male sub-group was analysed (R = -0.750; p 
= 0.02) – results shown in Figure 9.4. 
 
9.8.3. Effect of waist circumference on SCJ position 
  There was a strong negative correlation between age and distance between 
SCJ  and  PHPZ  (R  =  -0.525;  p  =  0.044)  –  results  shown  in  Figure  9.5.  This 
correlation was even stronger when the male sub-group was analysed (R = -0.767; p 
= 0.016) – results shown in Figure 9.6. 
 
9.8.4. Multiple regression analysis 
In multiple regression analysis the combination of both increasing age and 
body mass index was significantly associated with movement of the SCJ closer to 
the proximal HPZ (R
2=73.6%, P<0.001) with a strong trend towards significance for 
both individual variables (p=0.053 and p=0.088 respectively). 
 
9.9. Discussion 
Our results indicate that the position of the squamocolumnar junction relative 
to  the  proximal  high  pressure  zone  in  Helicobacter  Pylori  negative  individuals  is 140 
 
strongly  correlated  to  age.  Furthermore  the  association  is  stronger  in  males  and 
similar associations can be seen with increasing BMI and waist circumference. This 
is a cross-sectional study and while it confirms that increasing age and obesity are 
associated with proximal migration of the SCJ it cannot determine cause and effect. 
Nevertheless,  these  findings  would  be  in  keeping  with  previous  autopsy  studies 
which  suggest  cardia  mucosa  may  be  acquired  over  time  and  could  be  due  to 
columnar metaplasia of the most distal oesophageal squamous mucosa.  
If this effect is independent of age-related gastric atrophy, it would support the 
hypothesis that this is due to acid-induced metaplasia. It would suggest that obesity 
and more specifically the central (visceral) obesity seen in males, which correlates 
with waist circumference, may potentiate acidification of the most distal squamous 
oesophageal  mucosa.  This  could  be  explained  either  by  traditional  gastro-
oesophageal  reflux  or  by  ‘intra-sphincteric  reflux’  where  the  pH  step-up  point 
migrates across the SCJ due to distal opening of the LOS following meals. 
 
9.10. Conclusion 
The  position  of  the  squamocolumnar  junction  relative  to  the  proximal  high 
pressure zone correlates strongly with age, BMI and waist circumference in healthy 
subjects. This supports proximal migration of the squamocolumnar junction due to 
columnar metaplasia of the distal oesophageal squamous mucosa. 141 
 
Table 9.1. Baseline characteristics of study participants 
Parameter  Value 
Number of Subjects  15 
Sex 
Male 
9 (60%) 
Female 
6 (40%) 
Age (y)  25 (20 – 59) 
Age Range 
<30 y 
9 (60%) 
>30y 
6 (40%) 
Weight (kg)  75.0 (55 – 110) 
BMI (kg/m
2)  22.7 (18.6 – 34.7) 
BMI Range 
Normal (<25) 
11 (68.8%) 
Overweight (25-30) 
2 (12.5%) 
Obese (>30) 
3 (18.8%) 
Waist Circumference (cm)  82 (66 – 110) 
Distance from SCJ to PHPZ (cm)  3.59 (0.31 – 4.46) 
Values are medians (ranges) unless stated 142 
 
 
Figure 9.1. Fitted line plot of age versus distance between SCJ and PHPZ 
 
Figure 9.2. Fitted line plot of age versus distance between SCJ and PHPZ – males versus 
females 143 
 
 
Figure 9.3. Fitted line plot of body mass index versus distance between SCJ and PHPZ 
 
Figure 9.4. Fitted line plot of body mass index versus distance between SCJ and PHPZ – 
males versus females 144 
 
 
Figure 9.5. Fitted line plot of waist circumference versus distance between SCJ and PHPZ 
 
Figure 9.6. Fitted line plot of waist circumference versus distance between SCJ and PHPZ – 
males versus females 145 
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Chapter 10 
A Localised Decrease in Parietal Cell Density Occurs at the SCJ with 
Increasing Age in Asymptomatic Healthy Volunteers 
 
10.1. Introduction 
It has been hypothesized that gastric cardia mucosa may be pathological and 
represent acid-induced columnar metaplasia of the most distal oesophageal mucosa. 
We  have  shown  that  the  squamocolumnar  junction  moves  closer  to  the  proximal 
border  of  the  lower  oesophageal  high  pressure  zone  with  increasing  age.  This 
suggests proximal migration of the SCJ with progressive enlargement of the gastric 
cardia  may  occur  over  time.  This  would  be  expected  to  be  accompanied  by  a 
reduction in parietal cell density at the SCJ but how  much of this is due to age-
related gastric atrophy and is it associated with distal oesophageal acid exposure? 
 
10.2. Aims 
Our aims in this study were: 
i.  to investigate whether parietal cell density in the columnar mucosa at 
the squamocolumnar junction (SCJ) changes with age 
ii.  to  determine  whether  this  is  a  localised  phenomenon  or  associated 
with more generalised gastric atrophy 
iii.  to examine the role of Helicobacter pylori infection 147 
 
iv.  to  investigate  the  association of  SCJ parietal  cell  density  with  distal 
oesophageal acid exposure 
 
10.3. Subjects 
25 healthy volunteers (14 males, 5 Helicobacter pylori positive) were studied.  
 
10.4 Methods 
During  upper  GI  endoscopy,  biopsy  samples  were  taken  from  the 
macroscopic SCJ, 1cm distal to the SCJ, the gastric body and the gastric antrum. 
Biopsies  were  embedded  in  paraffin  blocks  and  5  micron  thick  sections  cut  for 
immunohistochemistry.  Parietal  cells  were  stained  and  visualised  using  a 
standardised  monoclonal  anti-H
+K
+ATPase  antibody  as  shown  in  Figure  10.1.  All 
slides were scanned via a digital scanner (Olympus, UK) and uploaded onto a slide 
server. A tissue image analysis programme (SlidePath, Dublin, Ireland) was used to 
quantify parietal cell density in each cell which was reflected as intracellular positive 
pixels. To allow correlation with acid exposure, pH studies were performed in 20 
subjects before and for 90 minutes after our standardised meal of two fishcakes and 
one rolled oats flapjack with 150ml water (Total calorie content = 526.35kcal).   
 
10.5. Analysis 
The  average  parietal  cell  density  in  a  minimum  of  4  sections  of  columnar 
mucosa per slide was reported as a percentage of the total cells per section. Acid 148 
 
exposure was calculated 5 - 6cm above the level of the fasting pH step-up point and 
calculated as % time pH<4.  
 
10.6. Statistical analysis 
Spearman’s rank correlation coefficient and the Mann-Whitney U test were 
used for analysis of non-parametric data. Results are medians and ranges unless 
otherwise stated. 
 
10.7. Ethics 
  The study was approved by West Glasgow Research Ethics Committee and 
informed consent was obtained from each participant. 
 
10.8. Results 
10.8.1. Parietal cell density 
  Median parietal cell density results are shown in Table 10.2. 
 
10.8.2. Age and parietal cell density 
There  was  a  significant  negative  correlation  between  increasing  age  and 
parietal cell density in the columnar mucosa at the level of the SCJ (R = -0.530, p = 
0.008). There was no significant correlation between age and parietal cell density 149 
 
1cm distal to the SCJ (R = 0.153, p=0.5), in the gastric body (R = 0.386, p = 0.08) or 
antrum (R = 0.117, p = 0.6). These results are displayed in Figure 10.2. 
In the Helicobacter pylori negative subgroup, parietal cell density at the SCJ 
of volunteers under 30 years old was significantly greater than those aged 30 years 
and over (6.8% (range 0 – 16.3%) v 0.4% (range 0 – 6.3%); p = 0.05). In contrast, 
gastric body parietal cell density was lower in the younger group (30.0% (range 19.9 
– 35.7%) v 34.5% (range 30.5 – 42.7%); p = 0.019. These results are shown in 
Figure 10.3. 
 
10.8.3. Distal oesophageal acid exposure and parietal cell density 
The median % time post-prandial oesophageal pH < 4 was 0.49% (0 - 19.96). 
There was no significant correlation between post-prandial distal oesophageal acid 
exposure and parietal cell density (R = 0.223, p = 0.3) – see Figure 10.4. 
 
10.9. Discussion 
Parietal cell density decreases with age in the columnar mucosa at the SCJ. 
This effect appears to be localised to the SCJ and is not seen 1cm distal to this or 
within the stomach suggesting it is not due to generalized age-related parietal cell 
atrophy.  Furthermore,  when  the  Helicobacter  negative  subgroup  was  analysed 
separately, while SCJ parietal cell density significantly decreased in the group over 
30 years of age, gastric body parietal cell density actually increased. There was no 150 
 
correlation between parietal cell density and conventional acid reflux, measured as 
%time pH <4 at 5 - 6cm above the fasting pH step-up.  
These  results  suggest  a  progressive,  localised  decrease  in  parietal  cell 
density at the GOJ with increasing age  which is due to a mechanism other than 
traditional ‘trans-sphincteric’ gastro-oesophageal reflux. While parietal cell  atrophy 
due to Helicobacter pylori infection could explain a reduction in parietal cell density, 
this would be expected to cause more generalized parietal cell atrophy affecting the 
gastric  body.  In  addition,  only  5  (20%)  of  our  subjects  were  Helicobacter  Pylori 
positive and sub-group analysis confirmed a reduction in SCJ parietal cell density 
with  increasing  age  in  the  Helicobacter  Pylori  negative  group.  These  findings 
therefore support the hypothesis that the gastric cardia is an acquired structure due 
to acid-induced columnar metaplasia. This may occur due to ‘intra-sphincteric reflux’ 
with the pH step-up point migrating across the SCJ due to distal opening of the LOS 
as we, and others in our group, have already described. 
 
10.10. Conclusion 
Parietal cell density decreases with age in the columnar mucosa at the SCJ, 
an effect localised to the GOJ and independent of, conventionally measured, distal 
oesophageal  acid  exposure.  These  results  support  the  hypothesis  that  cardiac 
mucosa  may  be  acquired  and  due  to  mechanisms  other  than  traditional  gastro-
oesophageal reflux. 151 
 
Table 10.1 Median parietal cell density results 
  Location of Biopsies 
Group  SCJ  1cm Distal to SCJ  Gastric Body  Gastric Antrum 
Total* 
5.4 
(0-16.3) 
26.5 
(6.7-34.7) 
31.2 
(19.9-42.7) 
2.5 
(0-21.3) 
<30 years old 
6.3 
(0-16.3) 
22.3 
(6.7-34.7) 
30.0 
(19.9-35.7) 
3.2 
(0-21.3) 
≥30 years old 
0.2 
(0-6.3) 
26.9 
(12.1-34.7) 
34.0 
(30.5-42.7) 
2.5 
(0-20.0) 
*Median (range in brackets) parietal cell densities are shown as % of total number of cells 
per biopsy section 
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Figure 10.1 Histology Slide showing parietal cells stained with monoclonal anti-
H+/K+ATPase antibody 
 
Figure 10.2 Fitted line plot of SCJ parietal cell density versus age 153 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.3. Bar chart of parietal cell densities at the SCJ and gastric body of Helicobacter 
Pylori negative subjects below and above 30 years of age 
 
Figure 10.4. Fitted line plot of distal oesophageal acid exposure versus SCJ parietal cell 
density 
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Chapter 11 
Discussion and Future Work 
7.1. Discussion 
This thesis describes a number of studies which provide further insight into 
the  possible  aetiological  mechanisms  which  underpin  the  development  of  acid-
induced distal oesophageal squamous mucosal damage. 
In examining the role of salivary nitrite in the pathogenesis of GORD using 
healthy volunteers (Chapters 6, 7 and 8), we have produced the most robust study in 
this area to date. We were able to effectively control for variability in dietary nitrate 
consumption, as demonstrated by the negligible basal salivary nitrite concentrations. 
Furthermore,  we  produced  an  excellent  range  of  salivary  nitrite  concentrations 
throughout these studies, over and above the normal physiological range. The total 
nitrite load was equivalent to that used in the previous study by Manning et al in 
which an increase in TLOSRs and acid exposure was seen following the infusion of 
a NO-generating infusion. However, in contrast to the study by Manning et al, by 
infusing  nitrite  solutions  intra-orally  without  the  addition  of  supra-physiological 
amounts of NO-promoting ascorbic acid, our study is more physiological in design. 
Despite this, these studies show no effect of salivary nitrite on gastro-oesophageal 
function,  GOJ  morphology  or  gastro-oesophageal  reflux  –  either  conventional  or 
short-segment. This suggests that salivary nitrite does not alter gastro-oesophageal 
function, the integrity of the gastro-oesophageal barrier or gastro-oesophageal reflux. 
A  criticism  of  these  studies  could  be  that  only  healthy  volunteers  were 
examined. This raises the possibility that an effect of salivary nitrite, and the luminal 156 
 
chemicals  it  generates  at  the  GOJ  following  ingestion,  that  is  isolated  to  reflux 
patients may have been missed as this group has not been evaluated. Theoretically, 
the epithelial damage produced by erosive oesophagitis might facilitate NO reaching 
the intrinsic muscle layers of the oesophagus making reflux patients more sensitive 
to the presence of luminal NO than our healthy volunteers. However, given that in 
these  studies  the  luminal  nitrite  concentrations  following  infusion  of  the  highest 
concentration solution were 10-fold the upper limit of the normal range, it is unlikely 
an effect has been missed even in subjects with an intact epithelium. 
The heterogeneous nature of reflux patients – from those with abnormal 24 
hour  acid  exposure  but  non-erosive  disease  to  patients  with  large  hiatus  hernia, 
long-segment Barrett’s oesophagus and severe (LA grade D) oesophagitis – makes 
them  a  difficult  population  to  study.  Moreover,  as  the  majority  of  patients  with 
confirmed  reflux  disease  are  likely  to  be  receiving  acid  suppressing  medical 
treatment with either a proton-pump inhibitor (PPI) or histamine-2 antagonist (H2A), 
attempts  to  study  this  population  may  be  complicated  by  the  phenomenon  of 
rebound  acid  hypersecretion.  This  occurs  after  discontinuation  of  anti-secretory 
therapy  and  previous  work  by  Gillen  et  al  (172)  and  Fossmark  et  al  (173)  have 
shown this effect to be prolonged, lasting at least 8 weeks in  Helicobacter Pylori 
negative  individuals  following  PPI  withdrawal.  In  symptomatic  patients  it  is 
impractical  to  request  discontinuation  of  acid  suppression  for  this  duration.  As  a 
result, being able to study ‘true’ reflux patients without pharmacological influence to 
either  reduce  or,  through  rebound  hypersecretion,  increase  acid  secretion  is 
increasingly difficult. 157 
 
  These studies are also the first studies examining the effect of salivary nitrite 
on  GORD  to  utilise  high-resolution  pH  and  manometry  techniques.  While  this 
provides high-frequency and detailed steady state analysis of gastro-oesophageal 
function,  the  volume  of  data  produced  and  the  complexity  of  data  analysis  is 
challenging and time-consuming. It has necessitated the development of our own in-
house  custom-made  analysis  programmes  and  the  development  of  a  specific 
thermal drift correction to ensure the most accurate data analysis (151). However, 
being  able  to  confirm,  with  a  high  level  of  significance,  previously  published 
physiological  meal-induced  changes  at  the  GOJ  confirm  our  study  protocols  and 
methods are both sensitive and robust. 
  A  further  question  is  whether  the  effect  of  salivary  nitrite  on  gastro-
oesophageal function, morphology and reflux could be masked by the effect of the 
meal itself? It is well recognised that fatty meals, as result of increased CCK release 
secondary to duodenal fat, reduce LOS pressure, delay gastric emptying and may 
stimulate TLOSRs (22;54;55). Similarly, high volume meals may stimulate TLOSRs 
through gastric distension (23). We purposefully selected a low-fat meal to minimise 
the risk of this occurring. Importantly, the meal selected for these studies is likely to 
be both a lower volume and lower fat meal than the battered fish and chips meal 
used in the study by Manning et al (93) where an increase in TLOSRs and acid 
exposure is described following infusion of their NO-generating solution. Accordingly, 
it is unlikely that the meal used in our studies would mask any effect of salivary nitrite 
especially in view of the range of salivary nitrite concentrations produced. 
  The  semi-recumbent  position  was  used  in  all  studies,  however,  this  is  not 
physiological following a meal as most patients are either mobile or sitting upright. 158 
 
Therefore, the question remains whether these results are applicable to ambulant 
subjects or would be seen in subjects sitting upright following a meal. 
  The manometry studies in Chapters 6 and 8 also confirm, for the first time 
using high-resolution manometry, distal opening of the LOS after meals. This is a 
possible  mechanism  of  distal  oesophageal  acidification  independent  of  traditional 
‘trans-sphincteric’  reflux.  Although  in  our  detailed  studies  of  GOJ  morphology 
(Chapter 8) we did not see significant proximal  migration of the  pH step-up point 
across the SCJ this may be the result of examining a non-obese population in a 
semi-recumbent position.  
In  our  study  examining  the  effect  of  age  and  obesity  on  SCJ  position  in 
healthy  volunteers  (Chapter  9)  it  could  be  argued  that  the  results,  showing  a 
significant negative correlation between SCJ position relative to the proximal margin 
of  the  HPZ  and  age,  BMI  and  waist  circumference  respectively,  provide  in  vivo 
evidence to support the ‘acquired cardia’ hypothesis. Moreover, these results, which 
are more significant in the male sub-group, highlight a potential link to obesity and 
more specifically the visceral obesity which predominates in white males. This may 
be  important  in  the  pathogenesis  of  GOJ  adenocarcinoma  especially  in  the 
asymptomatic population. These results are underlined by the study in Chapter 10 
where a localised decrease in parietal cell density is seen at the SCJ. This appears 
to  be  independent  of  traditional  trans-sphincteric  reflux  measured  as  distal 
oesophageal acid exposure. 
However, both these studies have obvious limitations with small number of 
subjects  examined  and  limited  age,  BMI  and  waist  circumference  ranges. 
Importantly,  both  studies  are  cross-sectional  and  although  they  may  highlight  an 159 
 
association  they  are  unable  to  prove  cause  and  effect.  Despite  this,  the  highly 
significant correlations deserve further investigation. 
 
7.2. Future Work 
Although  our  studies  suggest  that  salivary nitrite  does not promote  gastro-
oesophageal  reflux  this  does  not  mean  that  the  luminal  chemistry  produced  by 
swallowed nitrite does not still have a role to play in carcinogenesis at the GOJ. The 
nitrosating species N2O3 and NOSCN are able to react with secondary amines and 
amides in gastric juice to form N-nitroso compounds which induce cancer in animal 
models  while  nitric  oxide  is  itself  known  to  be  mutagenic  at  high  doses.  To 
investigate  whether  a  causal  relationship  exists  between  salivary  nitrite  produced 
from dietary nitrate and neoplasia at the GOJ will require large scale epidemiological 
studies. 
The GOJ and, in particular, the highly mobile SCJ remains a difficult area to 
study in great detail. In these studies, like many others, we used X-ray localisation 
with fluoroscopy to determine the location of the SCJ. While this can currently be 
considered the ‘gold standard’ its use in prolonged studies and appropriateness for 
detecting episodic changes in GOJ morphology (e.g. TLOSRs) is significantly limited 
by  the  radiation  exposure  involved.  More  work  is  needed  to  develop  alternative 
techniques for investigating this dynamic and highly clinically important region. 
  Further work is also required to clarify the contribution of distal opening of the 
LOS  to  acidification,  inflammation,  metaplasia  and  neoplasia  of  the  most  distal 
oesophageal squamous mucosa. Future studies should be larger with greater range 160 
 
in age, BMI and waist circumference. They should examine the effect of both obesity 
and posture. In particular, the supine posture which promotes cephalic displacement 
of the diaphragm and may precipitate distal opening. It would also be important to 
formally quantify visceral adiposity by utilising CT or MRI scanning and to investigate 
the  effect  of  this  visceral  adiposity  on  the  structures  involved  in  maintaining  the 
normal anti-reflux barrier such as the position of the crural diaphragm relative to the 
GOJ.  Finally, further  in  vivo  evidence is required  to  support  the  ‘acquired  cardia’ 
hypothesis and subsequent studies may wish to examine the histology across the 
SCJ and gastric cardia in greater detail than simply quantifying parietal cell density. 161 
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